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The chick choriollantoic membrane (CAM) is a potentially useful model that can be 
used for in vivo as well as in situ studies. The use of the CAM does not pose much 
ethical challenges. In addition, its relatively easy availability and consistency in 
quality render it a convenient biological model for use in experiments requiring live 
tissues. Furthermore, the CAM has been used as an alternative to the Draize test for 
irritancy assessment. The vascularity and easy access to the CAM would allow it to be 
used in vasoactive studies, whereby the extent of drug absorption can be ascertained 
via change in blood perfusion as well as the change in diameter of the CAM vessels. 
To date, the CAM has not been compared with other membranes in terms of 
permeation profiles. This provided the impetus to conduct permeation studies with the 
CAM alongside other biological membranes so as to determine which biological 
membrane the CAM best represents.  
 
This study showed that the partial deshelling method was more suitable then the full 
deshelling method for preparing the CAM to investigate blood perfusion, vessel 
diameter and irritancy. The egg should ideally be deshelled at embryonic age 7 days 
to allow adequate maturation and to avoid damage to the fragile CAM. The CAM was 
useful for assessing irritancy, which was manifested as hyperamaemia, hemorrhage 
and clotting. Nicotine, glycerin and high concentrations of propranolol were found to 
cause irritancy to the CAM. Measurement using the laser Doppler perfusion imager 
(LDPI) was significantly affected by the amplitude and threshold settings. A software 
written using Matlab was found to be more efficient than the manual method for 
determining the changes in vessel diameter. Changes in vessel diameter were more 
SUMMARY 
 ix
sensitive and reliable than blood perfusion in response to the test substances. Changes 
in blood perfusion and vessel diameters with drug concentration were generally 
complex due to the compensatory mechanisms of the biological system. Nevertheless, 
glyceryl trinitrate was a potentially useful model drug for assessing the effects of 
formulation factors on drug absorption through biological membranes. The drug 
permeation studies revealed that the CAM best mimic the buccal mucosa, compared 
to skin and retina. This paves the potential of the CAM for use as a “live” in vivo 
model for assessing formulations for buccal delivery. Overall, the development of 
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A. The three Rs in experimentation 
The concept of Reduction, Refinement and Replacement was introduced in 1959. In  
spite of the three Rs initiative, it is of interest to note that the number of animals used 
for experiments is still on the rise (Festing, 2008). This trend has not abated even 
though the number of new drug submissions has been falling over these few years 
(Bhogal, 2009). Laboratory animals continue to play an important role in research, 
teaching and testing (Balls, 2009). It is crucial to persist in the search for alternative 
models of biological membranes in order to reduce the need for live whole animals. 
There are various experimental models, and the next section will discuss some 
examples that are currently employed in the pharmaceutical area.  
 
B. In vitro and in vivo models 
Numerous in vitro and in vivo test models are employed in the pharmaceutical 
industry, especially in the area of drug discovery and development. In vivo models are 
used in the study of pharmacological activity and toxicity, metabolism, 
pharmacokinetics and mechanism of action. The contention with such in vivo models 
is the ethical consideration surrounding the use of live animals. Some common live 
animals used as in vivo models in experiments include rats, mice and guinea pigs. 
Increasingly, there is a push towards the use of in vitro models in studies in view of 
the antagonism towards animal testing. In the campaign spearheaded by Russell and 
Burch in 1959 to adopt alternatives to in vivo methods, numerous in vitro concepts 
have been adopted (Straughan et al., 1996). In vitro models, such as cell lines derived 
from human tissues and computional programmes, do not make use of live animals. 
However, the use of in vitro models is fraught with complications. The in vitro 
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process bypasses the biotransformation processes that some drugs undergo in vivo. 
Furthermore, the test compound may be required to undergo modification so as to 
achieve the desired functionalities during in vitro testing, such as aqueous solubility 
enhancement, which will not be suitable for an in vivo situation. As such, the results 
garnered from such experiments would not be representative of the actions of the drug 
in vivo (Straughan et al., 1996). It is of particular interest to look at other current in 
vivo methods that take absorption, irritancy and permeation into consideration. 
Knowledge of these characteristics would enable pharmaceutical companies to 
appropriately tailor and improve on formulations so as to bring safe and effective drug 
products into the market. 
 
C. Drug absorption 
C.1. An overview 
Bioavailability of compounds is affected mainly by the absorption and metabolism 
that occur in the body. The distribution and metabolism processes hinge on the 
presumption that the drug is able to undergo absorption and enters the circulation of 
the body. In vivo drug absorption is one of the critical parameters used to determine 
bioavailability of a drug. The rate and extent of absorption of a drug from its dosage 
form into the systemic circulation is known as bioavailability. Drug absorption is a 
complex process which is influenced by numerous factors, including the surface area 
available for absorption, physicochemical drug properties, physiological variables and 
formulation factors (Pontiroli et al., 1989, Senel and Hincal, 2001, Subramanian et al., 
2004). For the oral route of administration, factors such as the constituents of the 
gastrointestinal fluid, rate of gastric emptying, disease state, drug metabolism and 
interaction between the drug and gastrointestinal fluid affect drug bioavailability. The 
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ultimate therapeutic effect of the drug is a function of the plasma drug concentration. 
Hence, one of the main goals of formulation studies is to enhance drug permeation 
across biological membranes. In the commonly used method of evaluating drug 
bioavailability, the drug is administered to an animal and its blood or urine is 
collected at different time intervals for assay. A plot of drug concentration of drug 
versus time is constructed and the area under the curve is used to indicate the extent of 
drug bioavailability. Computational and simulation methods which make use of curve 
fitting by compartmental analysis have also been employed, such as Wagner-Nelson 
and the Loo Riegelman methods (Cryan et al., 2007). Permeability and solubility of a 
drug can be interrelated to obtain an estimation of absorption with the maximum 
absorbable dose (Burton and Tullett, 1985). A method has to be sensitive and specific 
enough to accurately detect the change in blood drug level that reflects absorption, 
whether it is drug concentration in blood/plasma or metabolites in the urine. Hence, 
the instruments needed are relatively sophisticated and expensive. 
 
C.2. In vitro and in vivo models to assess drug absorption 
In vitro and in vivo models that have been used to assess the absorption of drugs 
include animal intestines, artificial membrane, caco-2 cells (Dash et al., 2001, Hugger 
et al., 2002, Mathieu et al., 1999, Walgren and Walle, 1999), cultured epithelial and 
endothelial cells (Audus et al., 1990), and live animals such as rabbits (Kang and 
Singh, 2005), monkeys, rats and beagle dogs (Keller et al., 2007, Pu et al., 2004). Cell 
cultures are prone to contamination by microorganisms, as well as cross-
contamination with other cell types. In vitro models have the potential for high 
throughput, but they do not possess biological factors such as enzymes, drug 
transporters or the cellular pathways through which drugs pass. The parallel artificial 
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membrane permeability assay (PAMPA) requires a long incubation time, which 
decreases its suitability for unstable compounds (Hidalgo, 2001). Graphical 
approaches to estimate human oral bioavailability from absorption, distribution, 
metabolism and excretion data and a pharmacokinetic approach that integrates with in 
vitro data have also been attempted (Cai et al., 2006, Mandagere et al., 2002). These 
methods are simple and do not require any biological tissues. The lipid composition 
of the PAMPA system can also be tailor-made to represent different lipid components 
present in the gut. However, PAMPA systems are unable to assess transcellular 
passive diffusion, which is the predominant route by which drugs are absorbed. The 
caco-2 cell lines, although capable of high throughput, are also unable to mimic the 
transport mechanisms in human tissue fully, and face the problem of inter-laboratory 
variability (Dressman et al., 2008).  
 
C.3. Advantages and limitations in the use of animal and human tissues 
The methods which involve animals are not only expensive but also time consuming. 
Human tissues are therefore preferred to animals but the availability of human tissues, 
especially large pieces of tissue, is subject to ethical considerations. This is 
particularly problematical when considerable quantities are needed. There are also 
considerable ethical concerns, thus making human tissues not as easily available. In 
addition, there are risks of diseases transfering to handlers of human tissues (Qvist et 
al., 2000). Moral issues are also brought into play when the potential donors are 
deceased, aborted human fetuses or even healthy volunteers. There is a moral 
obligation to use the human tissue in an appropriate and befitting manner. In the 
pursuit of alternatives, it would be ideal to have an in vivo model that is sensitive, 
inexpensive and capable of high throughput to handle the large number of samples 
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associated with formulation and related studies. Hence, the chick chorioallantoic 
membrane (CAM) is potentially a good candidate for an in vivo drug absorption 
model. 
 
D. The fertilized chicken egg and its chorioallantoic membrane  
D.1.  An Overview 
Chicken eggs (Figure 1) have been used in studies concerning developmental biology 
since the 19th century AD. An attractive factor is its reasonable price relative to other 
animal models. However, there are over 400 different breeds of chicken, with the 
White Leghorn breed being the most commonly used commercially to produce eggs. 
Upon fertilization, an egg takes about 20 hours from shell formation to when the egg 
is laid. After the egg is laid, the cooling of its contents causes the inner egg 
membrane, which is under the outer egg membrane located directly under the shell, to 
contract away from the shell, resulting in the formation of an air sac. Below the air sac 
is the inner egg membrane, followed by the chick chorioallantoic membrane (CAM). 
The CAM, which is found in fertilized egg, is derived from the fusion of 2 extra-
embryonic membranes: chorion and allantois. The chorion and allantois start to fuse 
together to form the CAM at about 4 days after the egg is laid (Romanoff, 1960). The 
incubation period of the chicken egg is 21 days. The day that the egg is incubated, 
which may not coincide with the day that it is laid, is known as embryonic age 0 day 
(EA 0). The second day is embryonic age 1 day (EA 1), followed by embryonic age 2 




Figure 1. Structure of a fertilized chicken egg 
 
D.2. The CAM 
Histologically, the CAM consists of three layers: ectoderm, mesoderm and endoderm 
(Fuchs and Lindenbaum, 1988). The characteristics of the three germ layers at the 
10th day of incubation are as follows. The ectoderm cells are flat and aligned in a 
single layer, with another one or two layers of cells beneath. The capillaries, which 
were previously located in the mesoderm are now found in the ectoderm layer. The 
mesoderm is an embryonic connective tissue with blood vessels passing through it. 
The respiratory capillaries are located on the outermost part of the mesoderm at this 
stage. The ectoderm is made up of largely cuboidal cells. Besides being a respiratory 
























blood vessels such as the vitelline vessels found on the surface of the yolk. The CAM 
is also involved in the transport of sodium and chloride ions from the allantoic sac 
which is located close to the amnion sac, and calcium from the eggshell to the 
vasculature. Through dilation of the associated blood vessels (known as 
chorioallantoic vessels), the embryo is able to avoid overheating for a relatively long 
time (Valdes et al., 2002, Burggren et al., 2004). The CAM is supplied with blood by 
the allantoic artery which stems from the chick embryo (Hochel et al., 1998). The 
CAM capillaries are known as the 1st order vessels. These vessels merge to form 2nd 
order vessels. Subsequently, 2nd order vessels merge to form 3rd order vessels. The 
CAM is sensitive to changes in oxygen tension and develops inflammatory responses 
to a  number of irritants (Staton et al., 2009).  
 
D.3. Applications of the CAM 
As the CAM is thin and transparent, the highly vascular structures located within can 
be easily seen. Hence, it was employed in vasoreactivity studies (Dunn et al., 2005). 
The vascularity of the CAM allows it to be used as a model to assess damage to the 
vasculature. It was used to assess the damage to vessels induced by phototherapy 
(Chin et al., 2004, Kelly et al., 2005, Hammer-Wilson et al., 2002, Saw et al., 2005b, 
Saw et al., 2005c) and neovascularization (Dimitropoulou et al., 1998, Lewis et al., 
2006, Patan et al., 1997, Pegaz et al., 2006, Romanoff, 1967).  Its immature immune 
system allows it to be used in irritancy testing. It was used in irritation studies as an 
alternative to the Draize test (Curren and Harbell, 2002, Daston and McNamee, 2005, 
Harvell and Maibach, 1998, Lagarto et al., 2006, Vinardell and Garcia, 2000) and also 
in the evaluation of inflammatory and growth responses to biomaterials, implants, 
smoke and contaminants (Cobb et al., 2003, Klueh et al., 2003, Melkonian et al., 
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2004, Uchil et al., 2004, Valdes et al., 2003). In addition, the immature endothelial 
cells of the CAM allow the implantation and growth of grafted tissue. Endometriosis 
lesions (Gigli et al., 2005, Nap et al., 2003, Nap et al., 2004, Nap et al., 2005, Navarro 
et al., 2003), fungus and virus (Fuller and Kolb, 1968, Gow et al., 2003, Hahon, 1959, 
McPhee et al., 1984) have been grafted and grown on the CAM. The optimum age of 
the CAM for use in graft procedures ranges from EA 9 to EA 12 (Ausprunk et al., 
1974). The acute and chronic inflammatory responses exhibited by the CAM in 
response to the presence of biomaterials have also been found to be similar to that of 
humans (Valdes et al., 2002). The CAM was utilized as a model for heart rate 
irregularities to assess the effect of drugs on heart rate (Hochel et al., 1998, 
Yoshiyama and Kanke, 2005a, Yoshiyama and Kanke, 2006, Yoshiyama and Kanke, 
2005b, Yoshiyama et al., 2003, Yoshiyama et al., 2004). It was used as a model for 
wound healing (Ribatti et al., 1999, Zaugg et al., 1999), myeloma (Ribatti et al., 
2003), diabetes (Yoshiyama et al., 2005), human skin (Kunzi-Rapp et al., 1999), 
human eye (Fitzgerald et al., 2002, Schmid et al., 1996) and endocrine system (Cobb 
et al., 2003). Some researchers had used the CAM as a platform to test compounds for 
angiogenic and antigiogenic properties (Brand et al., 2006, Forough et al., 2003, 
Richardson et al., 2005, Tanojo et al., 1999, Zacharakis et al., 2006), anti-
inflammatory properties (Brantner et al., 2002) and investigate the efficacy of 
permeation enhancers in photodynamic therapy (Keller et al., 2007, Saw et al., 2007a, 
Saw et al., 2007b, Saw et al., 2007c, Saw et al., 2007d). In addition, the CAM was 
used to investigate the role of growth factors during angiogenesis (Drenkhahn et al., 
2004, Gabrielli et al., 2003, Gabrielli et al., 2004, Maeda and Noda, 2003, Nico et al., 




D.4. Advantages and limitations of the fertilized egg and CAM as models 
Fertilized eggs are much less expensive and easier to handle than live animals. The 
egg is first disinfected and an opening made through the shell to expose the CAM for 
investigation. The CAM can be viewed directly through the opening that is kept 
sealed by the use of a transparent tape (Valdes et al., 2002). No restrainment of the 
CAM is necessary in comparison with other live animal models. The use of anesthesia 
or other pharmacological agents is also not necessary with the CAM (Dunn et al., 
2005). The CAM was largely used in studies whereby topical application of the test 
substance was employed. The accessibility of the CAM allows for numerous 
applications to be done with relative ease (Staton et al., 2009). Numerous 
formulations have been tested on the CAM. This provides useful information on 
formulation characteristics in view of the fact that the CAM can be used as a model 
for numerous conditions as well as human organs, as previously discussed in Section 
D.3. The CAM is more sensitive at EA 10 than EA 14. In the United Kingdom, 
fertilised eggs up to 10 days old can be used without the need for a permit for animal 
experimentation (Gow et al., 2003). This is line with the British Animal Welfare Act 
(1986) that considers an embryo as an animal only when it has reached half of its 
gestational age. In the case of the egg, this translates to the fact that eggs up to EA 10 
can be used for experimentation without restrictions. In Germany, eggs up to EA 10 
are classified as foodstuffs, which allow them to be used as a non-animal entity. In 
addition, ethics committee approval for the use of chicken eggs is not required in 
countries such as USA and Switzerland. The use of the CAM concurs with the 
initiative of the European Partnership which seeks alternative approaches to animal 
testing. The European Center for the Validation of Alternative Methods, as well as the 
European Partnership for Alternatives to Animal Testing, have accepted the use of the 
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CAM model as an alternative to animal testing. This is a step towards reducing 
experimental animal use. The CAM also possesses advantages over non-animal 
models, such as caco-2 cells, as it represents a whole in vivo system, unlike caco-2 
cells which are ultimately in vitro systems or at best, in situ. 
 
There are, however, a number of limitations associated with the use of fertilized egg 
and CAM. The short incubation period of the egg coupled with disturbances 
associated with the increasing embryo movements at older ages, decreases the period 
of time during which an egg can be employed for experimentation (Zaman et al., 
2009). In angiogenesis assays, the naked eye is used to assess changes in vasculature 
in response to drug instilled. This method is subjective and not sensitive to minute 
changes in vasculature dimensions. The use of instruments to measure dimensions and 
density of vessels expressed as fractional image area and vascular density index is 
more appropriate for quantification (Strick et al., 1991). The results may be affected 
by a number of confounding factors. For example, it is crucial to determine the 
angiogenic response of the CAM at the appropriate time frame. After 24 hours, only 
vasodilation occurs. Furthermore, the vessel density measured does not distinguish 
vasodilation from neovascularization. The latter refers to the proliferation of blood 
vessels in tissue not normally containing them, which can be determined by sequential 
photography. The CAM does not allow for large volumes of blood to be removed, in 
view of its small size and capacity. It is also not suitable for long term studies as the 
partially deshelled egg is prone to contamination and the developing embryo is very 
fragile (Valdes et al., 2002). Unlike animal models, such as the mouse, rabbit or dog, 
an egg is not suitable to investigate different routes of administration. Although it was 
used as an alternative to the human skin, it lacks the keratinized layer. There are a 
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number of factors that may affect the growth and development of the egg. These 
factors include the chicken breed used, the stage of development of the egg when it is 
placed into the incubator, the time lapse after it was laid and before incubation, the 
temperature of the egg when it is placed in the incubator and the size of the egg 
(Hamburger and Hamilton, 1992).  The effects of these factors were minimized in a 
study by using the same breed of eggs throughout the experiments, consistently 
incubating eggs of roughly similar lapse time and standardizing the size of the eggs. 
 
D.5. The CAM as a model for human tissue 
Table 1 summarises the features of the CAM in comparison with other biological 
membranes. The CAM lacks keratin and is not stratified. The CAM does not have 
cilia or mucus. The CAM, however, is very richly supplied with blood. The CAM 
does not contain tight junctions. The absence of tight junctions signify little barrier to 
drug permeation (McCormick et al., 1984). In view of these characteristics, the CAM 
would be structurally similar to the retina, buccal mucosa, lungs, placenta and blood 
brain barrier tissues as compared to other human tissues. The buccal route is of 
considerable interest due to the high permeability of buccal tissue that allows for the 
rapid attainment of therapeutic concentrations in the blood. Therefore, if successful as 
a buccal model, the CAM could be used to evaluate the biological absorption of 
vasoactive drugs by measuring blood perfusion. The highly vascularised nature of the 
CAM allows for the assessment of changes in blood perfusion. Hence, it may be 
possible to measure blood perfusion of the CAM using a laser Doppler perfusion 
imager (LDPI). Furthermore, the transparent matrix of the CAM does not 
significantly absorb nor scatter any incident visible radiation (Hammer-Wilson et al., 
2002). The application of a vasoactive drug on the CAM was postulated to modify its 
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blood perfusion in accordance with the mechanism of drug action. In addition, blood 
perfusion could be quantified by the laser Doppler perfusion imaging (LDPI) method 
to indicate the rate and amount of drug absorption. Another approach of assessing 




Table 1. Comparison of composition between the CAM and human tissues 
 
 
     








CAM X X X √ X X Unknown 
Skin √ √ √ √ X X √ 
Buccal mucosa X X X √ √ X √ 
Intestine X X X √ √ √ √ 
Lung X X X √ √ √ X 
Retina X X X √ X X X 
Nasal mucosa X X Pseudo √ √ √ √ 
Placenta X X X √ X √ √ 
Blood brain 
barrier 
X X X √ √ X √ 
X refers to absence of the characteristic whilst √ refers to the presence of the 
characteristic. Pseudo refers to the presence of pseudo stratification, which are cells 
that appear to be in layers. The term unknown indicates that the presence of enzymes 







E. The laser Doppler perfusion imager (LDPI) 
E.1. Principle of Operation 
The laser Doppler principle involves the use of a helium-neon laser light beam 
directed on a tissue sample with vasculature. The moving red blood cells in the 
vessels reflect the photons of light back at an altered frequency, i.e. the Doppler 
effect. Back-scattered light is collected and converted into signals that can be used to 
interpret the perfusion pattern of the tissue sample (Bircher, 1995) (Figure 2). The 
light source emitting the laser as well as the mirrors used to direct the laser beam unto 
the test sample is encased in the Doppler head and cannot be seen. The detector which 
converts the signals into perfusion units is likewise concealed within the Doppler 
head. Only the laser beam emitted from the Doppler head can be visually captured. In 
a nutshell, the method uses two-dimensional horizontal scanning of the tissue of 
interest, with a depth of up to a few hundred micrometers, resulting in the 
visualization of spatial variation (Miyai et al., 2005).  
 
    














The laser Doppler perfusion imager (LDPI) measures a parameter termed as 
perfusion. Perfusion is expressed as the average velocity of blood cells (V) multiplied 
by the concentration of blood cells (Equation 1). Perfusion is calculated automatically 
and expressed in arbitrary units of Volts.  
 
CVP ×=                                       Equation 1 
 
where  P = Perfusion in Volts  
 
The readings obtained are affected by ambient temperature and light as well as the 
physiological condition of the test sample. The readings are depicted as an image and 
a photo. The photo shows the test area, whilst the image depicts the test area with its 
corresponding perfusion values. The resolution of the photo obtained can be adjusted 
to requirement with no additional information required except extended waiting time 
for higher resolution photos. The resultant image is colour coded according to the 
magnitude of perfusion (Figure 3). The scale moves from black and dark blue, 
representing the lowest value of perfusion, to red representing the highest value of 
perfusion as detected in each particular perfusion measurement. This allows for easy 





Figure 3. A representative set of readings obtained in the LDPI measurement 
 
Besides the LDPI, other equipment used directly or indirectly to evaluate perfusion 
employ techniques such as fluorescence microscopy, intravital microscopy, isotope 
washout methods, capillaroscopy, optical coherence tomography, magnetic resonance 
imaging, laser Doppler flowmetry, near infrared spectroscopy, thermography and 
photoplethysmography (Mori et al., 2005, Wright et al., 2006).  
 
E.2. Applications of the LDPI 
The ease of use of the LDPI, as well as its non-invasive property, has resulted in its 
extensive use in various studies. The LDPI is a sensitive tool that is able to provide 
rapid assessment of changes in blood perfusion (Hoff et al., 2009). Characterization of 
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the forearm skin circulation (Fullerton et al., 2002b, Lantsberg and Goldman, 1990, 
Zhong et al., 1998, Wardell et al., 1994), cerebral blood flow (Nakase et al., 2002), 
basal skin blood flow during the menstrual cycle (Mayrovitz et al., 2007), retinal 
blood flow (Avila et al., 1998, Yoshida et al., 2003), colonic blood flow (Sakaguchi et 
al., 1990), skin microcirculation (Berardesca et al., 1995, Johannes Frank et al., 2001, 
Svedman et al., 1998) and even microvascular blood flow in animal muscles (Handley 
et al., 1990, Fuchs and Lindenbaum, 1988, Lam and Ferrell, 1993, Miyajima et al., 
2005, Monnet et al., 2006) have been conducted using the LDPI. The LDPI was used 
in a predictive study that computed tissue metabolic activity from evaluation of 
oxygen saturation based on tissue hemoglobin saturation and blood cell velocity 
(Binzoni et al., 2003). The LDPI was proven useful in numerous studies that 
investigated medical conditions and treatments that are associated with changes in 
blood perfusion. Such studies include the investigation of change in perfusion with 
epicondykitis (Ferrell et al., 2000), postherpectic neuralgia (Stucker et al., 1997), 
rheumatic disease (Ferrell et al., 2000, Murray et al., 2004), reflex sympathetic 
dystrophy (Sorensen et al., 1996) and peripheral arterial obstructive disease (Morales 
et al., 2005). Last but not least, treatments that induce change in blood perfusion have 
been investigated. Some of these studies revolve around treatments such as smoking 
cessation (Fulcher et al., 1998), capsaicin treatment (Andrews et al., 1999, Krogstad et 
al., 1999, Van der Schueren et al., 2008), corticosteroid therapy (Hoffmann et al., 
1998, Jacobi et al., 2006, Noon et al., 1996, Sommer et al., 1998), analgesia (Andrews 
et al., 1999, Arildsson et al., 2000a, Arildsson et al., 2000b, Li Kam Wa et al., 1990) 
or irritation induced by various drugs (Andrews et al., 1999, Arildsson et al., 2000a, 
Arildsson et al., 2000b, Bjarnason et al., 1999, Fullerton et al., 2002a, Goon et al., 
2004, Li Kam Wa et al., 1990, Sutinen et al., 2000, Wigger-Alberti W. et al., 2001), 
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penetration of methyl nicotinate (Issachar et al., 1998), permeation enhancer studies 
(Tanojo et al., 1999), gingival blood flow in the treatment of peridontitis (Donos et 
al., 2005), peripheral vascular responses to temperature (Freccero et al., 2003, Miyai 
et al., 2005), blood flow analysis during hemodialysis (Davis and Johns, 1990, 
Niwayama and Sanaka, 2005) and change in perfusion during burns (Bray et al., 
2003, Droog et al., 2001). 
 
E.3. Advantages and limitations of the LDPI 
Laser Doppler perfusion imaging is a non-invasive procedure that can be automated. 
It is simple to use, sensitive and produces fast, objective and accurate results. A large 
specific test area can be monitored continuously without compromising resolution. 
Measurement does not involve direct contact with the test site. This is advantageous 
as physical contact may elicit certain responses, such as change in blood flow rate of 
the tissue. Studies have shown that blood perfusion measurements obtained with the 
LDPI were reproducible and that the technique was selective in measuring the 
perfusion of the object in question (Stucker et al., 1995). The LDF employs the same 
principle of operation as the LDPI but involves the use of a probe that has to be in 
contact with the test object in order for blood perfusion measurements to be 
registered. Physical contact with the CAM should be avoided as a LDF study 
conducted on chick yolk sac membrane detected a drop in blood flow when the probe 
was in contact with the yolk sac membrane (Gush et al., 1990). Movement of the LDF 
probe can also potentially cause a shift in baseline blood flow measurement (Goode 
and Klein, 2002). The LDPI can decrease the incidence of movement artifacts and 
also achieve more reproducible results with a larger area of measurement in contrast 
to the results obtained with the LDF. Differences between malignant and normal 
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tissues can also be investigated with the LDPI but not the LDF as the LDPI has the 
ability to measure perfusion differences on adjacent sites (Bornmyr et al., 2001, 
Humeau et al., 2007). In addition to improvement in sensitivity, the LDPI also gives 
an average perfusion map of the measured area after scanning it. Validated blood flow 
measurement methods such as hydrogen clearance, flow through glass capillaries and 
radioactive microsphere methods were conducted (Tanaka et al., 1974). The findings 
from these methods were found to be correlated with LDF measurements, indicating 
that the LDF could provide quantitative determination of blood flow. A comparison of 
the LDPI with the LDF and dynamic thermographic imaging had shown good 
correlations (Harrison et al., 1993, Zhong et al., 1998). This indicates that LDPI 
measurements correlated well with the validated blood flow measurement methods. In 
one such study, blood was diluted in saline to obtain various concentrations of red 
blood cells, which was then run through using an infusion pump. Separate perfusion 
measurements with the LDPI were taken and compared to the estimated flow 
parameter values. The estimated flow parameter values were calculated by 
multiplying the product of the velocities of the red blood cells and their various 
concentrations aided by a mechanical flow stimulator. The perfusion readings showed 
a correlation coefficient of 0.996 between the perfusion through a mechanical flow 
stimulator and the estimated flow parameter (Wardell et al., 1993). The LDPI is also a 
cheaper method as compared to the use of other techniques involving various 
equipment and methodologies. Examples of alternate blood flow monitoring systems 
include diffuse correlation spectroscopy, dynamic contrast enhanced data and model 
independent convolution analysis to monitor tumor blood flow or the use of dynamic 
susceptibility contrast enhanced magnetic resonance imaging to obtain an 
autoregressive moving average model that is also in need of correlation and validation 
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(Murase and Miyazaki, 2007, Murase et al., 2003, Yu et al., 2005). Furthermore, 
constant improvements are being made to the LDPI, with the possibility of real time 
perfusion imaging with high speed camera function. 
 
At higher concentrations of red blood cells, the perfusion values obtained may 
underestimate the true perfusion values, as the red blood cells will cause multiple 
scattering and produce successive Doppler shifts (Wardell et al., 1993). Other 
limitations include the possibility of artifacts when the Doppler head is shifted. 
Artifacts can thus be avoided by maintaining a constant setup of the LDPI throughout 
the experiments. Increasing advances in technology have narrowed down the depth of 
measurement to a few hundred µm. In the case of the CAM, this depth penetration is 
sufficient as the thickness of the CAM generally does not go beyond 200 µm. In 
addition, calibration standards may not be sufficient to simulate the actual 
physiological conditions that may affect blood perfusion. However, motility standards 
based on flow models have been derived that are able to provide a suitable gauge for 
the calibration of the LDPI (Rajan et al., 2008).  
 
E.4. Assessment of drug absorption on the CAM 
The use of the LDPI to measure perfusion of the CAM has not been reported. On the 
other hand, two methods involving LDF had been employed (Broekhuizen et al., 
1995, Nakazawa et al., 1986). One of these involved optical Doppler tomography, 
which is a hybrid of the LDF and optical coherence tomography. Optical Doppler 
tomography presents the results in the form of a structural image. The image depicts 
the diameter of the vessels and its dimensions, and the image is colour coded to 
represent the velocity within the test areas. It was employed to study the change in 
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blood perfusion following pharmacological and photodynamic therapies and the 
topical application of glyceryl trinitrate. Using this method, the normal perfusion of 
blood in the CAM was found to be pulsatile (Chen et al., 1998, Zhongping Chen et 
al., 1997).  The other method, which is based on Fourier domain optical Doppler 
tomography, is more sensitive. Fourier domain optical Doppler tomography was used 
on the CAM as an imaging tool to demonstrate in vivo blood perfusion (Zhang and 
Chen, 2005). However, this is an expensive method that has not yet been extensively 
studied. Screening of vasodilators was attempted with cellular biosensing approach. 
An example of which includes the monitoring of changes in the artery of the bovine 
myocardium (Haruyama, 2006), but it is an in vitro assay. There are several other 
methods to measure blood flow (Chernyavsky et al., 2010, Li et al., 2010, Lin et al., 
2009, Qian et al., 2009). The term blood flow refers to the speed or velocity of blood 
cells movement, whereas perfusion includes the added dimension of blood 
concentration in a specific volume. The basic concepts of blood flow and blood 
perfusion are comparable, with the assumption that the space through which blood 
cells pass through does not change dramatically.  
 
Laser Doppler perfusion imaging is generally regarded as an improved technique over 
most blood perfusion measurement methods and its application on CAM has not been 
well investigated. Since the CAM is a potentially useful model for assessment of drug 
absorption, there is an impetus to develop the CAM-LDPI method as an alternative to 
animal studies.  
 
Vasoactive drugs are known to be capable of enhancing the effects of other drugs 
(Hadgraft, 1999). Vasoconstrictors restrict blood perfusion and allow the drug to 
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remain in the area of application for an extended period to exert a prolonged effect 
locally. Vasodilators enhance blood perfusion and can potentially facilitate the 
transport of accompanying bioactive drug into the systemic circulation to exert its 
effect at other parts of the body. The clearance of a small molecule during maximal 
vasodilation in skin was found to increase by 4 folds (Clough and Gush, 2009). The 
CAM is thus potentially useful for screening additives that can be added to drug 




F.1. An overview 
Digitized images have been used in numerous scientific applications. The use of 
imaging allows for clear visualization of the process being studied and the analysis of 
the obtained images provides for more comprehensive data of the mechanisms 
involved or sequential changes that took place. Applications that employ digitized 
images include gamma scintigraphy, single photon emission computed tomography, 
nuclear imaging and positron emission tomography among others. These methods 
have been used to monitor particles through the lungs to determine the pathways of 
drug absorption (Cryan et al., 2007). Information on the microvascular density in 
tumour tissue was obtained after staining and measuring the fluorescent area with an 
image analysis system (Pendleton et al., 1998). Diagnosis of oral premalignant and 
malignant lesions can also be achieved with digitized endoscopic imaging (Qian et al., 
2009). Image analysis was used in the scoring of cytotoxicity studies on cell cultures 
(Tillmann et al., 1989). Scanned images were able to assess ischemic damage, with 
ischemic areas presented in a different colour from normal unaffected areas (Wexler 
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et al., 2002). Pharmaceutical processes also make use of video imaging processes to 
monitor the movement of particles, such as those in a pan coater (Pandey and Turton, 
2005). For the purpose of focused discussion in relation to the CAM, imaging related 
to irritancy and toxicity screening, and measurement of vessel diameters will be 
discussed in greater detail.  
 
F.2. Pertinent applications, advantages and limitations 
Non-invasive in vivo magnetic resonance imaging was used to determine the 
diameters of the carotid arteries (Manka et al., 2000). Imaging processes provided 
speckle maps which were used to determine artery diameters by counting the number 
of pixels (Forough et al., 2005). In addition, visualization of surface microvessels can 
be obtained with optical microscopy (Wright et al., 2006). Digital image analysis was 
used to measure the size of retinal vessels (Remky et al., 1996). Graphical 
programmes, such as LabView, are other examples that have been used to measure 
the external diameters of vessels in retinal tissue (Yu et al., 2003).  
 
F.3. Imaging studies conducted on the CAM 
Numerous imaging processes have been used to measure vascularity parameters of the 
CAM, in a bid to characterize the CAM vessels. Measurement of vessel diameter was 
executed by casting the CAM in resin, followed by observation under a light 
microscope for details of its vascular structure (Dimitropoulou et al., 1998, Reizis et 
al., 2005). Although these studies are highly informative and provide detailed 
information of the vascular structure of the CAM, such experimental procedures 
would result in sacrificing the egg, without the possibility for subsequent experiments. 
Microscopy of the CAM can also be achieved to obtain black and white images of the 
 INTRODUCTION 
 24 
vasculature (DeFouw et al., 1989). Modeling of the CAM vessels can be further 
conducted with the discrete vasculature (DIVA) thermal model, which was 
successfully applied to the vessels in the eye (Flyckt et al., 2006). Vasodilation can 
also be assessed with high resolution ultrsonography, but this is an invasive method 
(Moens et al., 2005). The use of image analysis also enabled angiogenesis to be 
quantified with the use of fractal dimension, vascular density as well as change in 
length and number of vessel branches obtained from images taken with a 
photomicroscope or computer assisted morphometry (Ribatti et al., 2000, Thompson 
and Brown, 1987). Wall differentiation and minute details of the capillary had been 
elucidated with the use of electron microscopy analysis studies (Mysliveckova and 
Rychter, 1975). Measurements of blood perfusion through the CAM cardiovascular 
circulation and vessel diameters have been investigated using a Doppler spectral 
optical coherence tomography microscope system (Davis and Johns, 1990). In 
addition to the high cost of equipment, optical coherence tomography is unable to 
resolve blood flow profiles, thereby resulting in a reduction of optical contrast of 
blood. A ‘shadow’ is typically seen below the blood vessel, which adds to the noise in 
the Doppler measurement and thus, inaccuracies in the blood flow measurements. 
Nonetheless, the use of such digitized images without sacrificing the egg has its 
advantages and serves two purposes. Firstly, this accentuates the ‘refinement’ of the 
experimentation process, a step toward alternative methods to animal testing. 
Secondly, the imaging process is non-destructive and thus allows further experiments 
to be conducted on the same egg, allowing for more intensive use of the egg, before 
ultimately sacrificing the egg at the end of the experiment. Besides reducing cost, 
biological variation can also be reduced. The CAM can be used repeatedly on the 
condition that it has not been subject to toxic effects that would consequently affect its 
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response to further testing. A computer software may be required for rapid and 
automated measurements of the diameters of vessels in the CAM. Quail CAM had 
been characterized, as a test bed for the modeling of  retinal vessels, as the smaller 
size of the egg allowed for easier manipulation and handling (Vickerman et al., 2009). 
However, this translates to a smaller surface area of CAM to perform experiments or 
to assess for vascular changes. Chicken CAM is normally preferred by most 
researchers in experimental studies due to their larger size as well as their ready 
availability when compared to other types of eggs. 
  
G. Irritancy 
G.1. An overview 
Toxicity refers to a broad term that can be classified into different categories. Some 
examples include acute toxicity, subacute and subchronic toxicity, irritation and 
sensitization, phototoxicity and mutagenesis. Currently, toxicity is assessed from the 
determination of lethal dose with cell lines, such as neuronal, muscle and myocardium 
cells or animals (Allen et al., 2008). The use of cell lines is hampered by problems 
relating to cell stability, viability and contamination (Allen et al., 2005). Tests 
performed to determine irritancy include cell proliferation assays, cell membrane 
integrity tests and basal cytotoxicity tests. The CAM has been extensively used as an 
alternative to the Draize test in the assessment of ocular irritation.  
 
G.2. Irritancy assessment using the CAM 
The 2 main assays that employ the CAM to test for irritancy are HET - CAM (hen’s 
egg test - chorioallanoic membrane) and CAMVA (choriallantoic membrane vascular 
assay) test methods. These 2 tests differ in the age of CAM used and criteria for 
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assessing irritancy. In the HET – CAM test, the CAM at either EA 9 or EA 10 is 
employed. In contrast, more mature CAM at EA 10 or EA 14 is employed in the 
CAMVA test (Spielmann et al., 1997). The test substance is placed on the surface of 
the exposed CAM and vascular changes in the CAM are then examined with the 
naked eye. Irritancy of the test substance is scored appropriately, in conjunction with 
the various vascular changes seen and in the time frame that it occurs. This would be 
explored in greater detail in Section B.2. in the Methods section.  
 
The HET – CAM test takes into consideration the time lapsed before the 
manifestation of respective irritancy effects. The CAMVA test determines the 
concentration of the test material that causes an irritancy effect in 50% of the eggs. 
The irritation index calculated from the HET – CAM test takes into account the 
appearance of haemorrhage, vessel lysis and coagulation that may have occurred after 
the introduction of the test substance. For the CAMVA test, the endpoint is generally 
regarded as the emergence of bleeding and/or ghost vessels. Ghost vessels refer to 
vessels that are devoid of blood and appear transparent. Many variations of these 
methods to assess irritancy with modifications in the interpretation of the results have 
since evolved and adopted. CAMVA test is currently used as a screening tool by the 
cosmetic industries in the United States of America. On the other hand, the HET-
CAM is one of the four in vitro methods recognized by the regulatory authorities in 
Europe, with regard to the assessment and classification of severe eye irritants. The 
HET-CAM test is also used for safety testing of cosmetics (Liebsch and Spielmann, 
2002). The Organisation for Economic Co-operation and Development implemented a 
stepwise approach to the evaluation of dermal and eye irritancy and the HET-CAM 
test is one of the methods adopted (Mancebo et al., 2008). In general, the easy 
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accessibility of the CAM allows for fast assessment of responses to test substances 
and information on the irritancy of the test substances. The manifestation of irritancy 
in the CAM with severe irritants can sometimes be seen as early as within 10 s upon 
application of the irritant.   
 
H. Permeation studies 
Permeation studies predominantly make use of a diffusion cell to assess the amount 
and rate of drug that passes through membranes such as the skin. This will be 
discussed in the following section. Permeation assays can also be conducted with the 
use of caco-2 cells. Monolayers of these cultivated intestinal epithelial cells are used 
to assess the mechanism of transport, as well as the quantification of the permeated 
amount of the test substance (Alsenz and Haenel, 2003). Caco-2 cell culture models 
can be used to obtain an apparent permeability index. This apparent permeability 
index is only valid under strictly linear conditions, where the transfer rate of the test 
substance across the membrane of caco-2 cells is proportional to the amount of test 
substance placed on the membrane. Ultimately, an in vivo condition cannot be fully 
reproduced (Ingels and Augustijns, 2003). Other methods of assessing permeation 
involve the use of computational approaches that may involve one or more of the 
following: calculation of log of the oil-water partition coefficient, partial least squares 
method, neural networks, the Abraham descriptors which consists of datasets 
developed by the Abraham group, polar surface area, 3D molecular field models that 
relate to physiochemical properties, quantum chemical approaches and prediction of 
biological permeation with electrotopological state indices that make use of the 
topological and electronic environment of each atom in a molecule (Malkia et al., 
2004). On-line visualization of the diffusion of a dye through skin using confoccal 
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laser scanning microscopy has also been employed. However, the fluorescence 
gradient for the dermis part of the skin is only limited to the first few micrometers, 
preventing the investigation into permeation beyond the limit of detection (Grams et 
al., 2004).  
  
H.1. Franz transdermal diffusion cell  
The drug solution is added to the donor compartment which is separated from the 
receptor compartment by a membrane. A constant area through which the permeation 
of the drug occurs is maintained throughout the experiment. The solution in the 
receptor compartment is constantly stirred with the aid of a magnetic stirring bar to 
ensure that no concentration gradient of the drug builds up. The receptor compartment 
possesses a side arm where samples are withdrawn for assay. Sampling occurs at pre-
set intervals and the amount of drug present in each sample determined. The 
cumulative amount indicates the total amount of drug that has permeated through the 
membrane and the time taken for the permeation process is used to calculate the rate 
of drug permeation. In the study of transdermal drug delivery, the whole setup is 
maintained at a constant temperature of 33°C to mimic the physiological condition of 
the skin. Although the Franz cell is predominantly used for transdermal studies, it has 
also been used to assess the permeation of drugs through other biological membranes. 
 
H.2. Principle of operation 
Diffusion cells consist of 2 basic models, one-chambered and two-chambered cells. 
The one-chambered cell is most commonly used to assess transdermal permeation. 
The membrane being studied is placed across the receptor compartment. The test 
substance is placed on the membrane and its diffusion through the membrane to the 
 INTRODUCTION 
 29 
receptor compartment is monitored. The test substance is used at a sufficiently high 
concentration to maintain a concentration gradient for diffusion to occur and for 
accurate analysis. The two-chambered cell consists of a donor compartment and a 
receptor compartment separated by a membrane. The donor compartment is filled 
with a solution of the test substance. The permeation of the test substance from the 




The Franz cell is an example of a one-chambered diffusion cell. It however has a cell 
top above the membrane, which can be employed as a donor chamber. The Franz cell 
was used extensively in studies to evaluate the permeation of substances across 
human skin. It can also be used in conjunction with confocal microscopy (Yu et al., 
2005). Some examples of permeation studies performed with the Franz cell include 
the investigation on the effects of glycol ethers (Venier et al., 2004), clobetasol 
propionate (Borges et al., 2003), permeation enhancers (Kikwai et al., 2005, Zwadlo-
Klarwasser et al., 2001) and new drug delivery systems on drug permeation through 
biological membranes (Dayal et al., 2005). In addition, the effect of synthetic 
membranes on permeation (Dias et al., 1999) and the effect of formulation 
development have also been studied (Pawar and Majumdar, 2006).  
 
H.4. Advantages and limitations 
Results obtained using the Franz cell with the same compound on different days were 
found to be similar, indicating the reproducibility of the Franz cell method (Akomeah 
et al., 2007). The Franz cell setup may be programmed to automatically replace any 
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sample volume withdrawn with an identical volume of fresh medium into the receptor 
compartment. However, some diffusion cells are not designed to perform this 
operation. As such, the volume of the receptor medium would be gradually reduced 
and unless this is taken into consideration, the results may not be accurate. Franz cells 
are fragile as they are made of transparent glass and transparency allows the user to 
note any presence of air bubbles developing for necessary corrective actions to 
remove them. In systems made from Teflon ®, the opacity of the Teflon ® does not 
allow for easy detection and removal of air bubbles. The presence of air bubbles may 
result in an incorrect sample volume and thus affect concentration analysis (Rapedius 
and Blanchard, 2001).  
 
The Franz cell uses membranes in its assessment of drug permeation. The use of 
biological membranes as opposed to in vitro cell cultures to measure permeability has 
its advantages. The permeability of water through buccal mucosa was evaluated using 
a TR146 cell culture model that was designed to mimic buccal epithelium (Nielsen 
and Rassing, 2000). It was found that the porcine buccal mucosa, a frequently used 
model to represent human buccal mucosa, formed a tighter barrier than the cell 
culture. The use of membranes in the assessment of permeation is more realistic than 
the use of cell cultures. Furthermore, the Franz cell is capable of giving a good 
approximation of the permeation rates of different substances through different types 
of membranes (Zorin et al., 1999). As such, the Franz cell can be used to assess drug 
permeation through the CAM as well as other biological membranes to allow for 





H.5. Assessment of drug permeation using the CAM 
Membrane transport studies with the use of the CAM have been attempted. The test 
substance is applied on the CAM and washed away after an appropriate time interval, 
to determine the amount of test substance unabsorbed (Saw et al., 2005b, Saw et al., 
2005c, Saw et al., 2007d). However, no permeation studies were carried out with the 
CAM on the Franz cell. Based on its structural characteristics, the CAM has been 
postulated to mimic certain biological membranes, such as the buccal, retina or human 
skin. However, comparisons of the CAM and other biological membranes had not 
been made nor were these studies carried out to determine the drug permeation 
profiles using the CAM as an in situ biological barrier. As such, this study will 











In the design and development of dosage forms, it is of interest to know how various 
formulation additives affect absorption. The CAM is an inexpensive and easily 
available biological model that may be employed to assess drug absorption as a 
function of blood perfusion and vessel dimension changes. It is a transparent matrix, 
highly vascularised and does not possess much ethical restriction with regards to its 
use. Hence, it has been used in numerous studies to evaluate irritancy effects of test 
substances, as a model for various types of organs and conditions, and in the 
evaluation of angiogenesis. The LDPI is a fast and rapid tool to determine blood 
perfusion, and has been extensively used to characterize blood perfusion of various 
organs, assess blood perfusion in disease states as well as evaluate changes in blood 
perfusion on drug treatment. However, the application of the LDPI has not yet been 
used to assess blood perfusion of the CAM. In addition, the change of vessel diameter 
with the CAM in conjunction with changes in blood perfusion has not been evaluated. 
Furthermore, the CAM has yet to be compared with other biological membranes in 
terms of permeation properties. 
 
It is important to identify a model vasoactive drug that can be used on the CAM to 
evaluate the influence of pharmaceutical ingredients on drug absorption. The model 
drug should ideally exert a definable dose response relationship on the CAM. Using 
the same amount of model drug, the ingredient that increases drug absorption will 
elicit a greater change in blood perfusion or change in vessel dimension. The extent of 
influence on drug absorption can be determined by assessing the degree of change of 
blood perfusion and vessel diameter. In this project, the primary aim is to study the 
feasibility of the CAM model to evaluate drug absorption based on changes in blood 




1. The CAM, in conjunction with LDPI and video digital imaging, is a useful in 
vivo model that provides a rapid and sensitive method to assess the absorption 
of vasoactive drugs. 
The response of the CAM to a vasoactive drug can be determined by the 
changes in blood perfusion and vessel diameters of the CAM. 
The reactivity of the CAM can also be used to screen and assess test 
substances for irritancy effects. 
2. The isolated CAM can be employed as an in vitro model with the Franz cell to 
assess drug permeation through certain biological membranes. 
 
B. Objectives 
1. Optimize conditions of the CAM and LDPI to carry out blood perfusion 
measurements for assessing absorption of vasoactive drugs. 
2. Employ the CAM as a screening tool for irritation effects 
3. Screen for suitable drugs to be used in blood perfusion measurements 
4. Study response of vessel morphology to drugs by imaging 
5. Compare the permeation profiles of the CAM and other biological membranes 
to determine which biological membrane it best represents 
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A. Materials 
A.1. CAM  
Freshly laid fertilized specific pathogen-free (SPF) chicken eggs of the White 
Leghorns species were purchased from Agri-Food and Veterinary Authority of 
Singapore (AVA), Singapore. The White Leghorns species is the most commonly 
used chicken species for experiments. It is also the most popular commercial species 
of egg laying chicken used because of its superior egg laying capabilities. The white 
egg shell of this egg variety allows for greater ease of candling when checking the 
viability of the eggs (Leighton et al., 1985). 
 
A.2. Blood perfusion and imaging studies 
Two forms of glyceryl trinitrate, GTN 0.5 mg per tablet, (Angised™, 
GlaxoSmithKline) and GTN 1 mg/mL (Merck, Germany) were used as a model drug 
(Table 2). Other model drugs used included propranolol (Zuellig Pharma, China), 
theophylline hydrate BP (Janson Chemicals, Singapore) and caffeine BP (Luen Wah 
Medical Company, Singapore). Sodium chloride (Merck, Germany), glucose 
monohydrate (Merck, Germany) and deionized water were used in the preparation of 
solvents.  
 
Other solvents and test substances employed were liquid paraffin (Merck, Germany), 
glycerin (BDH, England) and 70% ethanol (Far East Distillers, Singapore), N-methyl-
2-pyrrolidone (NMP, International Specialty Products, USA), L-nicotine (>99%, 
Acros Organics, USA) and glucagon (Novo Nordisk, USA). Purified agar, Sabouraud 




Table 2. Properties of model drugs used  
Drug Mechanism of action in humans Log partition 
coefficient 









Propranolol Antagonism of beta – adrenergic 
receptors 
3.48 295.8 61.7 1, 2, 5, 7.5, 15 and 30 mg/kg; 50, 
100, 150, 200 and 250 ng/mL 
Theophylline Antagonism of adenosine receptors -0.02 198.2 7360 1.5, 2, 2.5, 3, 3.5, 20, 30, 40, 50 
and 60 mg/kg 
Caffeine Increase in cAMP levels, inhibition 
of Ca2+ influx, inhibition of PDEs 
and antagonism of adenosine 
receptors 
-0.07 194.2 0.0216  2, 4, 6, 8 and 10 mg/kg 
Glyceryl trinitrate Release of nitric oxide which 
stimulates guanylate cyclase  
1.62 227.1 1380 Tablet: 0.0125, 0.025, 0.05, 0.1, 
0.15 and 0.2 mg/kg 
Injection: 0.01, 0.03, 0.05, 0.1, 
0.15, 0.2 and 0.5mg/kg  
Glucagon Possibly affects cAMP levels Not available 3485 Low 0.1% w/v 
Menthol Not available 3.38 156.3 420 2% w/v 
cAMP: cyclic adenosine monophosphate, PDE: 3’,5’-cyclic-nucleotide phosphodiesterase 
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USA) were employed for sterility testing of the cleansphere. The cleansphere provides 
an isolated and clean environment for experimental procedures.  
 
A.3. Franz cell diffusion studies 
L-Nicotine (Acros Organics, USA) and glyceryl trinitrate, 1 mg/mL (Merck, 
Germany) were used as model drugs. Shed King Cobra skin from Ophiophagus 
hannah was a gift from Khon Kaen University, Thailand. Pig abdominal skin, buccal 
mucosa as well as retina tissue were obtained from 4-month old Yorkshire-Duroc mix 
breed female pigs (Animal Holding Unit, National University of Singapore). 
Disodium hydrogen orthophosphate dodecahydrate (BDH Chemicals, England), 
sodium dihydrogenphosphate dehydrate (Nacalai Tesque, Japan) and sodium chloride 
(Merck Germany) were used to prepare isotonic phosphate buffer. 
 
A.3.1. HPLC studies 
Sodium acetate (Sigma-Aldrich, USA), triethylamine (Sigma Aldrich, USA), glacial 
acetic acid (Merck, Germany), deionized water and methanol (Fisher Scientific, USA) 
were used to prepare the mobile phases for analysis of nicotine and GTN. 
 
B. Methods 
B.1. Preparation of the CAM 
Two methods were employed to prepare the CAM for experimentation. Both 
procedures were performed aseptically in a clean environment provided by the 
Cleansphere (CA100, Safetech Limited, USA). The eggs were deshelled entirely or 
partially and returned to the incubator (Brinsea, England). The surface of the CAM 
was examined at different time intervals with the naked eye. 
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B.1.i. Full deshelling method 
The entire exterior of the egg (EA 3 and EA 4) was swabbed with 2 types of 
disinfectants, 70 % ethanol and 10 % povidone iodine, prior to manipulation. The egg 
was then cracked into a petri dish to expose the CAM completely for examination 
(Figure 4a). The petri dish was then covered with a lid and placed in the incubator. 
The condition of the sample was examined and its blood perfusion measured at daily 
intervals. 
 
B.1.ii. Partial deshelling method 
The entire exterior of the egg (EA 7) was disinfected as described in Section B.1.i. A 
hole of about 2 cm in diameter was made at the blunt end of the egg (Figure 4b). The 
two outermost egg membranes were then removed to reveal the CAM for 
examination. The hole was then covered with parafilm previously sprayed with 70 % 
ethanol. The egg was then placed in the incubator and the condition of the CAM was 




Figure 4. Deshelling methods: (a) Complete exposure of CAM by full deshelling 
method and (b) Partial exposure of CAM by partial deshelling method 
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B.1.iii. Assessment of egg weight during incubation 
The weights of 10 eggs were individually measured daily for the duration of the 
incubation period. The change in weight over time was used to indicate the growth 
rate of the embryo. This method was used to determine if the growth of the eggs is 
normal under the incubation conditions. If embryo development is normal, a linear 
relationship between incubation time and loss in egg weight will be observed. The 
weight loss can be attributed to the loss of water from the egg as the embryo develops. 
 
B.1.iv. Measurement of CAM thickness 
The thickness of the CAM was measured with the use of a micrometer (Mitutoyo, 
Japan). Measurements were taken at 3 different sites of the CAM and the average 
readings reported. 
 
B.2. Assessment of vessel morphology & irritancy 
The CAM from fertilized egg (EA 7) was prepared by the partial deshelling method. 
Visual assessment of the vessels and surface of the CAM with the naked eye was 
performed after the application of each test substance. Assessment of irritation effects 
such as hyperaemia, hemorrhage and clotting were performed. Hyperaemia is 
indicated by an increased amount of blood, resulting in congestion. Hemorrhage 
refers to bleeding on the surface of the CAM while clotting refers to coagulation 
whereby blood forms clumps. Time dependent scores for each irritation effect were 
then assigned in accordance with the grading system developed in the Luepke Method 
as shown below (Table 3). Photographs of the CAM were obtained using a 
stereomicroscope (SZ61, Olympus, Japan) connected to a colour video camera (DP71,  
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Table 3. Grading system for irritation 
 
Score Time taken for 
manifestation of 
irritation effect 
Hyperaemia Haemorrhage Clotting 
≤ 0.5 min 5 7 9 
> 0.5 to 2 min 3 5 7 
> 2 to 5 min 1 3 5 
 
 
Cumulative score Irritation potential 
< 1.0 Negligible 
1.0 to 4.9 Slight 
5.0 to 8.9 Moderate 
9.0 to 21.0 Strong 
 
Olympus, Japan) and computer with an image managing software (DP Controller, 
Olympus, Japan). 
 
B.3. Investigation of egg parameters affecting blood perfusion 
B.3.i. Embryo Age 
Eggs of different embryonic age were used to examine the influence of CAM maturity 
on consistency of blood perfusion readings. CAMs of EA 8 – 18 were investigated in 
this study. 
 
B.3.ii. Consistency of egg temperature 
The method to measure blood perfusion in the CAM was improved by the inclusion 
of a heated egg cup to maintain a constant egg temperature. A temperature-controlled 
egg cup, that was connected to a water bath (Grant Instruments, England), was 
fabricated to hold the egg after it was removed from the incubator for blood perfusion 
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measurement (Figure 5). The egg cup was warmed by a heated water jacket in an 
attempt to keep the temperature of the egg constant during blood perfusion 
measurements. Measurement was made with and without the use of the temperature-
controlled egg cup. 
 
The relationship between the temperature of the heated water jacket and the resultant 
temperature of the egg cup was first established by setting the temperature of the 
heated water jacket from 40 to 50 ºC at increments of 1 ºC each time. The 
corresponding temperature of the egg cup was measured with an infrared thermometer 
(Fluke, Netherlands). The initial setup was allowed to equilibrate for 2 h, following 
which, subsequent change in temperature required 30 min of equilibration time to 
achieve a constant temperature. From the results, the temperature of the egg cup was 
adjusted to about 37 ºC and reproducibility in blood perfusion measurement over time 
was determined and compared with that determined without the use of the 
temperature-controlled egg cup. 
 
 
Figure 5. Photograph of the water-jacketed egg cup connected to a circulating heated 
water bath. 
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B.4. Investigation of influence of LDPI parameters on blood perfusion 
measurement 
The laser beam was switched on for 15 min prior to perfusion measurements to allow 
the beam to equilibrate to room temperature with normal ambient light. The test 
sample was placed on a black cloth to minimize the extent of extraneous back-
scattered light from the background. Perfusion readings were made at the same 
location on the CAM for meaningful comparison. All measurements were carried out 
at least in triplicates. 
 
An orthogonal array design of L25 (54), 4 variables (distance, area, amplitude and 
threshold) at 5 levels each was conducted (Table 4 and 5). The sum of the readings for 
each variable at each level was denoted by the K value while the impact of the 
variable was denoted by the Rk value. The Rk value was determined by obtaining the 
difference between the highest and lowest K values for each variable. The variable 
with the greatest influence was indicated by the highest Rk value. 
 
A partial factorial study was further conducted on the 4 variables at 5 levels each to 
determine the optimal setting to be used for each parameter. The effects of scan speed 
and resolution setting on the readings were also determined, following optimization of 
the abovementioned LDPI parameters.  
 
The variables were further investigated with univariate analysis to confirm the results 
obtained from the partial factorial and orthogonal array design (Table 6). 
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Parameters Level 1 Level 2 Level 3 Level 4 Level 5 
Amplitude 0 3 5 7 10 
Threshold 0 3 5 7 10 
Measurment 
area (mm2) 






10  13  15  17  20  
 
B.4.i.  Amplitude 
The blood perfusion value measured by the LDPI was amplified by the software. 
Amplitude refers to the enhancement of the blood perfusion value by a certain 
multiplication value. The minimum amplitude value is 0 and the maximum level is 10. 
  
B.4.ii.  Threshold 
Threshold refers to the discrimination level between the background and the object of 
measurement. When the total amount of back-scattered light from the measurement 
site was lower than the threshold level set, no Doppler signal was recorded. A 
perfusion measurement was obtained only when the total amount of back-scattered 
light from the measurement site was higher than the threshold set. The minimum 
threshold value was 0 and the maximum level was 10.  
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Table 5. The L25 (54) Taguchi design matrix 










1 1 1 1 1 
2 1 2 2 2 
3 1 3 3 3 
4 1 4 4 4 
5 1 5 5 5 
6 2 1 2 3 
7 2 2 3 4 
8 2 3 4 5 
9 2 4 5 1 
10 2 5 1 2 
11 3 1 3 5 
12 3 2 4 1 
13 3 3 5 2 
14 3 4 1 3 
15 3 5 2 4 
16 4 1 4 2 
17 4 2 5 3 
18 4 3 1 4 
19 4 4 2 5 
20 4 5 3 1 
21 5 1 5 4 
22 5 2 1 5 
23 5 3 2 1 
24 5 4 3 2 




Table 6. LDPI parameters studied with CAM in the univariate analysis 
Level LDPI Parameters 
Level 1 Level 2 Level 3 Level 4 Level 5 Level 6 Level 7 Level 8 Level 9 Level 10 Level 11 
Amplitude 1 2 3 4 5 6 7 8 9 10 11 
Threshold 1 2 3 4 5 6 7 8 9 10 11 
Measurement area 
(mm2) 
2 x 5  2 x 6  2 x 7  2 x 8  2 x 9  2 x 10  2 x 11  2 x 12  2 x 13  2 x 14  2 x 15  
Distance between 
Doppler head and 
CAM (cm) 
10  11  12  13  14  15  16  17  18 19  20  
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B.4.iii.  Area of measurement 
In a study carried out by Gush et al. (1990), it was observed that the yolk of the egg 
contributed to the perfusion values, due to the particles present in the yolk undergoing 
Brownian motion. Hence, in this study, the measurement site was confined to the area 
of interest, i.e. the CAM vessels, as much as possible. Measurement sites of different 
sizes were evaluated to determine the measurement area required to capture the blood 
perfusion level of the CAM vessels accurately. The smallest measurement width 
needed by the LDPI was 2 mm, thus, all measurement areas investigated were with 
dimensions of 4 mm2 or larger. 
 
B.4.iv.  Distance of sample from laser head 
The distance between sample and laser beam aperture located in the Doppler head, 
was varied and the resultant perfusion readings were obtained.  
 
B.4.v.  Scanning speed and resolution 
Scanning speed refers to the time delay between two consecutive perfusion values 
from adjacent measuring sites and thus, the total time required to capture an entire 
image. Resolution refers to the geometrical distance between two consecutive 
measurement sites. These parameters were independently investigated from the partial 
factorial study once the optimal parameters were determined. 
 
B.4.  Drug studies 
The blood perfusion of the CAM was first monitored and the drug administered only 
when blood perfusion values of the CAM were found to be constant. An equilibration 
period of 15 min was generally necessary to allow the blood perfusion of the CAM to 
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stabilise. Thirty µL of each drug at various concentrations were applied topically to 
the CAM surface and the changes in blood perfusion investigated. Propranolol, 
theophylline and caffeine solutions were prepared with normal saline. Two forms of 
GTN were used. Sublingual GTN tablets were dissolved in an appropriate amount of 
normal saline to give the required concentration. The injection form of GTN was 
diluted to the required concentration with 5 % w/v glucose monohydrate solution. The 
pH and osmolality of some of the test substances were determined with a pH meter 
(Hanna Instruments, USA) and a vapour pressure osmometer (Wescor, USA) 
respectively. In addition, some control substances were also tested to assess their 
effects on blood perfusion. These substances include glycerin, ethanol, N-methyl-
pyrrolidone and glucagon.  
 
B.5.  Imaging studies 
B.5.i.  Imaging of CAM surface  
The egg was held in an egg holder that was placed underneath a stereomicroscope 
(SZ61, Olympus, Japan) connected to a colour video camera (DP71, Olympus, Japan) 
and computer with an image managing software (DP Controller, Olympus, Japan). 
This study was performed in a laboratory with constant ambient temperature of 23°C. 
An equilibration period of 15 min was allowed before images of the CAM were taken 
at 1 min intervals prior to the administration of the test substance at the 15th min time 
point. The time interval between image capture was further reduced so as to capture 
immediate and small changes in vessel diameter that might have occurred after the 
application of the test substance. 
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B.5.ii.  Image processing 
The diameter of the vessel was measured from its digitized image using a software 
written with Matlab R2007b (Figure 6a). The software employs a canny filter to 
extract a black and white binary image from a colour image in order to facilitate 
image processing. In the case of the CAM, the vessels would show up as white pixels 
against a background of black pixels. Each pixel in the binary image is assigned a 
value (Figure 6b). A white pixel was assigned a value of 1 and a black pixel was 
assigned a value of 0. The white pixels were detected by the software methodically 
and the diameters of the vessels determined. 
 
B.5.iii.  Measurement of vessel diameter 
The pixel units were calibrated into physical units of measurement such as µm with 
the aid of a micrometer image included in the same folder as the CAM photos. The 
various segments composed of white pixels were assigned a cumulative value and the 
diameters of these segments were subsequently computed in microns. Drugs that were 
previously found to be vasoactive were employed in this study. 
 
B.6.  Permeation studies with the Franz diffusion cell 
B.6.i.  Sample preparation 
Different biological membranes were investigated. They included fresh and frozen 
CAM, king cobra snake skin, pig skin, pig buccal mucosa and pig retina tissue. The 
test biological membrane, together with a synthetic membrane, was then fixed on a 
Teflon disc and mounted on the Franz diffusion cell. 
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B.6.ii.  Synthetic membrane 
A synthetic membrane composed of regenerated cellulose (Sartorius Stedim Biotech, 
France) was used to support the test biological membrane in the Franz diffusion cell. 
The synthetic membrane with a pore size of 0.45 µm was cut into a circular disc to fit 
the top of the receptor compartment. The test biological membrane was placed on top 
of the synthetic membrane.  
 
B.6.iii.  CAM 
The eggs were incubated for different periods of time to obtain CAM of different 
embryonic age. The CAM was harvested by first making a hole at the blunt end of the 
egg with a sharp pair of forceps. The eggshell was then cut into half along its length 
and the contents of the egg emptied, leaving the CAM adhered to the underside of the 
shell underneath the inner shell membrane. Normal saline was used to wash the 
surface of the CAM following which the CAM was carefully removed from the inner 
shell membrane with a pair of forceps. The CAM was rinsed in normal saline again 
and immediately used in the permeation study or frozen for use at a later date. The 
thickness of the CAM was also measured with a micrometer at three different 
locations.  
 
B.6.iv.  King cobra skin 
The shed king cobra skin was washed and dried at room temperature before being cut 
into discs and stored at room temperature. The skin disc was hydrated by soaking in 
isotonic phosphate buffer in a covered petri dish for 30 min prior to use.  
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B.6.v.  Pig skin 
Freshly harvested pig skin was frozen at -30oC and thawed prior to preparation. The 
hair on the specimen was trimmed with a pair of scissors and the harvested skin cut 
into appropriate sizes. The skin was then rinsed with normal saline and soaked in 
isotonic phosphate buffer for 30 min prior to use.  
 
B.6.vi.  Pig buccal mucosa 
The sample supplied consisted of the buccal mucosa with the underlying fat and 
muscle tissue. Hence, the specimen was first treated by soaking in hot water at 60ºC 
for 2 min to facilitate the removal of the mucosa layer from the base material tissue 
with a pair of forceps. The buccal mucosa was then washed with normal saline and 
soaked in isotonic phosphate buffer for 30 min prior to use.  
  
B.6.vii. Pig retina tissue 
The retina tissue was carefully removed from the back of the pig eyeball using a pair 
of forceps. The retina tissue was then washed with normal saline and soaked in 
isotonic phosphate buffer for 30 min prior to use.  
 
B.6.viii. Assembly of the Franz diffusion cell 
Permeation studies were carried out with the use of the Hanson Microette® apparatus 
(Hansons Research. USA). The apparatus consisted of six Franz diffusion cells in a 
vertical arrangement (Figure 7 and Figure 8). Each diffusion cell consisted of a lower 
receptor compartment and an upper cell top that could serve as the donor 
compartment. The test substance was placed into the donor compartment. The donor 
compartment was connected with the receptor compartment by a central orifice of  














Figure 7. Photograph of the Franz cell used: (a) Clamp to hold setup in place (b) Site 
for membrane placement (c) Thermostated jacket (d) Receptor Compartment (e) Hole 
for introduction of test substance (f) Donor compartment (g) Side arm for introduction 
of fresh medium (h) Side arm from which samples are withdrawn (i) Magnetic stirrer 
 
 
Figure 8. Diagram of the cross section of the Franz cell setup: (a) Clamp to hold setup 
in place (b) Site for membrane placement (c) Thermostated jacket (d) Receptor 
Compartment (e) Hole for introduction of test substance (f) Donor compartment (g) 
Side arm for introduction of fresh medium (h) Side arm from which samples are 














diameter 15 mm. The test membrane, with an underlying synthetic membrane, was 
placed on a Teflon disk with a central orifice of diameter 8 mm or 15 mm. A synthetic 
membrane was used to provide additional structural support. The fixture was then 
fastened between the donor and receptor compartments with the use of a clamp. The 
donor compartment was filled with 1 mL of drug solution. The receptor compartment 
was filled to its capacity with 7 mL of isotonic phosphate buffer. The membrane was 
allowed to equilibrate in the Franz diffusion cell for 1 h prior to sampling using a 
system of six syringes connected to a vacuum-controlled autosampler. Sampling was 
conducted over pre-determined time intervals. Sink conditions were maintained with 
the continuous use of a helix stirrer set at 600 rpm, as well as with the continuous top 
up of fresh isotonic phosphate buffer in the receptor compartment following the 
withdrawal of a sample from the receptor compartment at specific time intervals. The 
setup was maintained at a constant temperature of 37 oC. The constant temperature 
was provided by a water jacket controlled by a circulator water bath (Hanson 
Instruments, USA). The samples collected were analysed by HPLC according to the 
procedure described in Section B.6.ix. 
 
B.6.ix.  HPLC analysis 
B.6.ix.a. Nicotine 
The quantification of nicotine was performed with reversed-phase HPLC using a C-18 
column (Hypersil, 5 µm, 4.6 mm x 200 mm). The mobile phase consisted of 0.05M 
sodium acetate and methanol in the proportion of 88:12 v/v, with 0.5 % triethylamine. 
The pH of the mobile phase was then adjusted with glacial acetic acid to pH 4.2. Flow 
rate was set at 1 ml/min with sample injection volume of 20 µL and nicotine assayed 
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spectrophotometrically at 259 nm. The retention time obtained was between 6.5 to 7.5 
minutes, as reported in the literature (Pongjanyakul et al., 2002, Berner et al., 1992). 
Under these conditions, the calibration plot for nicotine between 0.0005 % and 0.2 % 
v/v demonstrated good linearity and reproducibility (r2 > 0.99). 
 
B.6.ix.b. GTN 
The quantification of GTN was performed with reversed-phase HPLC using a C18 
column (Hypersil, 5µm, 4.6 mm x 200 mm). The mobile phase consisted of HPLC 
grade methanol and deionized water in the proportion of 73:37 v/v. Flow rate was set 
at 0.9 mL/min with sample injection volume of 20 µL and GTN assayed 
spectrophotometrically at 210 nm. The retention time obtained was between 3.5 to 3.6 
min. Under these conditions, the calibration plot for GTN between 0.0032 % and 
0.045 % v/v was obtained. 
 
B.6.ix.c. Data analysis 
Sink conditions were maintained in the receptor compartment by the maintenence of a 
constant amount of medium in the receptor compartment, as supplied by the addition 
of fresh medium after the withdrawal of sample. As such, the amount of drug that 
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srT nCVnCVnM                                   Equation 2 
 
where  MT[n] = Cumulative amount of drug transported across the membrane at time 
t, C[n] = Concentration of the drug in the receptor medium, Vr = Volume of the 
receptor medium, Vs = Volume of sample removed for analysis at each sampling 
point and ∑{C[n-1]} = Summation of the previously measured concentrations. 
 
Steady state flux, an indicator of absorption, can then be established by Fick’s first 








                                      Equation 3 
 
Where  J = Steady state flux, Q = Amount of drug that permeated through the 
membrane, t = Exposure time, A = Area of application, Kp = Permeability coefficient 
and CD = Concentration applied to area of application 
 
The cumulative amount of drug that permeated through the membrane per unit area 
Q
/A can be calculated and plotted as a function of time, t. Steady state flux, J can be 
obtained via linear regression analysis of the initial linear portion of the plot. Further 
comparison can be made with permeability coefficient, Kp values. The Kp value was 
obtained by dividing the steady state flux value by the concentration of drug applied. 
A total of 3 determinations were obtained for each permeation study. 
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B.7.  Statistical Analysis 
The normality of the data was assessed with the Kolmogorov-Smirnov test. Statistical 
analysis of the data obtained was performed using one-way ANOVA. Assessment of 
the influence of LDPI parameters on blood perfusion measurements were conducted 
with a orthogonal array design using Minitab (Version 14, Minitab Inc, USA) with 
significance level set at 0.05. Linear correlation of data was tested with the Pearson 
correlation test. Statistical analysis of the changes in blood perfusion values and 
vessel diameters were performed using the paired samples T-test for individual eggs. 
The tests were performed using the statistical software SPSS for Windows (Version 
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A.  Preparation of the CAM 
A.1.  Full deshelling method 
It should be pointed out that various methods involving complete deshelling of the 
egg have been employed since the 1970s. In the earlier studies, the egg was de-shelled 
and its contents placed in a container under saturated humidity conditions with either 
1 – 2 % carbon dioxide throughout the whole incubation period or in 5 – 6 % carbon 
dioxide after 10 days of incubation (Bartholomew and Crawley, 1980, Dunn et al., 
2005). Other methods described the use of containers in the form of polyethylene film 
across a ring stand (Tuan, 1980) and petri dishes with or without a polyethylene film 
to hold the contents of the egg (Lugassy. et al., 2006, Tufan. et al., 2004). The latter 
method was employed in this study and termed as full de-shelling method. If the 
CAM were present, it might be injured when the egg was cracked into halves and the 
content transferred into the sterile petri dish. Hence, eggs at EA 3 and EA 4, when the 
CAM has not completely formed, were used. 
 
The survival rate of the embryos using the full deshelling method was generally low. 
The cracking caused the yolk of some of the eggs to leak (Figure 9a). Yolk leakage is 
usually an indication of injury leading to poor survival rates (Richardson and Singh, 
2003). Only 32 % of the eggs survived beyond a day after cracking the shell. When an 
embryo died, the CAM blood vessels were gradually devoid of blood because of the 
failure of the circulatory system and the CAM appeared translucent (Figure 9b). For 
those that survived more than a day, the histological development of the embryos as 
well as their blood vessels was generally delayed and abnormal when compared to the 
normal unshelled egg embryo development process. Fully deshelled embryos did not 
proceed to form distinct organs and limbs such as the feet and wings that were  
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Figure 9. (a) Viable embryo (b) Dead embryo 
 
expected at that embryonic age (Hamburger and Hamilton, 1992). This retardation of 
growth with the full deshelling method was previously reported (Tuan, 1980) and 
damage to the CAM was also documented (Samkoe and Cramb, 2003). Such a drastic 
technique also increases the risk of suffocation as the porous egg shell, which allows 
gas and water to permeate through the pores, is removed and replaced by a petri dish 
(Vogelaar and Boogert, 1925). Water is not able to permeate through the petri dish 
and water condensation occurred on the cover of the petri dish. The content of the egg 
being transferred into a petri dish allowed for a greater degree of expansion and 
freedom of movement than was provided for in the shell, thus the membrane had a 
possibility of being stretched considerably. As such, any measurements gleamed from 
the CAM was not as consistent nor accurate as the CAM was not in its natural state 
and its properties may have been altered in light of being in an unconfined space. 
Such an ex ova system was also hampered by the exposure of the chick embryo to the 
environment as opposed to the sheltered and controlled environment provided by the 
egg shell. The survival rates of the embryos in the earlier studies were not reported. In 
 
(a) (b) 
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the present study, it was clearly demonstrated by the poor survival rate that the 
complete deshelling method was harmful to the embryo. Hence, the complete 
deshelling method did not appear to be a viable method for preparing the CAM for 
experimental studies. Another point in favour of the use of the partial deshelling 
method is the availability of a cup-like cavity with measurable exposed CAM area. 
This allows for a fixed area for drug diffusion when experiments to determine 
pharmacokinetic parameters are carried out. 
 
A.2.  Partial deshelling method 
Other more technically challenging methods that have been described in the literature 
are the dropped membrane and Zwillig techniques. The dropped membrane method 
involves the formation of a window in the blunt end of the egg with the use of a drill. 
Negative pressure, provided from the sucking mechanism of a rubber bulb, is 
introduced prior to the removal of the inner shell membrane from the egg 
(McCormick et al., 1984). In the Zwillig method, a hole is drilled through the CAM to 
remove the albumen so as to create a false air sac where the CAM will continue to 
grow without being attached to the inner shell membrane (Zwilling, 1959). Improper 
coverage of the hole can affect oxygen tension. This should be avoided as it was 
found that changes in oxygen tension can lead to changes in CAM vascularity (Strick 
et al., 1991). The partial deshelling method was adapted from the dropped membrane 
technique. In the partial deshelling method, older eggs with a higher chance of 
survival as compared to the eggs used in the full deshelling method were employed. 
The basic structure of the CAM would have already been formed in these 
embryonically older eggs.  
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Preliminary investigations were carried out to determine the optimal embryo age for 
partial de-shelling to prepare the CAM. As the CAM had not developed fully before 
EA 4, partially egg deshelling can only be carried out after this age. Deshelling eggs 
from EA 4 to EA 6 proved to be a very delicate task as the CAMs were still very 
fragile. After EA 7, the CAM was found to adhere too strongly to the egg membrane, 
making it more challenging and precarious to separate the CAM from the 2 outermost 
membranes, often resulting in bleeding after the deshelling procedure. The CAM was 
found to adhere strongly to the inner shell membrane at EA 8 and beyond 
(Dimitropoulou et al., 1998), hence making deshelling increasingly non viable.  
 
After preliminary investigations, it was decided that the eggs for CAM measurements 
would be partially deshelled at EA 7 and placed in the incubator to stabilize and 
mature till EA 9, the desired EA for experimentation on the CAM. This allowed the 
CAM sufficient time after the partial deshelling process to recover before 
experimentation. This also helped to eliminate problematical eggs that would 
succumb to the trauma of partial deshelling during the interim period. The CAM was 
visually assessed before experimentation, to ascertain that the CAM appeared healthy. 
Healthy CAMs should possess vessels that are free of bleeding or shrinkage, yolk 
bright yellow in colour and the embryo showing signs of activity.  
 
The partial deshelling method was found to be more successful when compared to the 
full deshelling method as the average egg survival rate was around 50 % and often 
markedly higher. For the full deshelling method, measurements of the vessel 
diameters and assessment of a suitable embryonic age at which to prepare the CAM 
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was not carried out. Hence, only partial deshelling method was adopted for 
subsequent experiments.  
 
A.3.  Egg weight with incubation time 
The decrease in egg weight over time exhibited a linear trend as shown in Figure 10. 
The trend is consistent with that reported for water loss in chicken embryos (Snyder 
and Birchard, 1982). Water was lost at a constant rate during the incubation period as 
the permeable egg shell presented a constant surface area for water loss. This finding 
indicates that the handling and incubation conditions used were appriopriate and 
unlikely to affect the normal development of the egg. These findings also showed that 
the conditions in the incubator were relatively consistent and well controlled. 
 
















Figure 10. Decrease in egg weight over time (n = 10) 
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A.4.  CAM thickness 
The thickness of the CAM was reported to differ depending on the site of 
measurement. The thickness of the CAM under the air sac was found to be thinner 
than other parts of the egg. The average thickness of the CAM at EA 9 was 60.6 µm, 
with a coefficient variance of 22 %. The value obtained from this study was 
comparable to that reported (Reizis et al., 2005).  
 
B.  Influence of CAM on blood perfusion measurement 
B.1.  Embryo age 
Blood perfusion of the CAM was found to follow a normal distribution pattern (p > 
0.05) according to the Kolmogorov-Smirnov test for normality of data. This shows 
that the data from the CAM was normal, and hence can be subjected to statistical tests 
for normal data. The blood perfusion values showed less variation from EA 8 to EA 
14, beyond which, blood perfusion increased sharply and then decreased beyond EA 
16 (Figure 11). Measurements were not made at EA 7, which was the day deshelling 
was performed, to avoid any possible influences of the trauma of deshelling on the 
perfusion readings. The standard error of the readings generally increased with the 
embryo age. This could be due to the movement of the embryo as it aged and grew 
bigger. The diameters of vessels in the CAM generally ranged from 160 to 300 µm, 
with the diameters of some vessels reaching 500 µm, depending on the age of the 
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Figure 11. Baseline blood perfusion in CAM at different EA. The bars represent the 
standard error of the measurements. (n = 3 for each data point) 
 
Embryonic age of 14 -18 days is classified as the late stage of embryo development 
during which the microvasculature of the CAM is fully matured (Shumko et al., 
1988). This could have accounted for the sharp increase in blood perfusion of the 
CAM after EA 14. The subsequent decline was probably due to the degradation of the 
mesoderm in the CAM where the CAM vessels were located (Shumko et al., 1988). 
The choice of embryo age for experimentation was based on several factors. The 
chosen embryo age should give consistent blood perfusion readings with low standard 
error. This was to ascertain that any changes in blood perfusion were due largely to 
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the effects of the test substance and not because of natural fluctuations in baseline 
blood perfusion. From the preliminary perfusion readings made, the window for 
measurements was narrowed down to an EA range of 8 to 14 days. As mentioned 
previously, the CAM should be allowed time to recover from the trauma of  
deshelling at EA 7. Furthermore, the experiments were recommended to be performed 
3 days after deshelling in view of the potential of immune or inflammatory responses 
(Staton et al., 2009).  Taking the 2 abovementioned factors into consideration, EA 8 
was deemed too early for experimentation. The embryo at EA 13 had been reported to 
move considerably and hindered blood vessel measurements (Hammer-Wilson et al., 
2002). This eliminated EA 13 as being a suitable choice to perform blood perfusion 
measurements. The embryo was better developed at EA 10 than EA 9. This would 
increase the potential of embryo movement at EA 10, which would affect the blood 
perfusion readings obtained. It should be recalled that the fertilized egg at EA below 
10 is not considered as a “living” whole animal as yet and thus exempted from ethical 
considerations. It is also of interest to note that a previous study concerning an 
investigation into the hyperemic reaction of the CAM by epoxyeicosatrienoic acids 
found that only CAMs of EA 9 and no other age, gave 100 % positive responses to 
epoxyeicosatrienoic acids at a dose that was known to be angiogenic (Dunn et al., 
2005). This suggests that EA 9 was a sensitive age suitable for experimentation with 
regards to the suitability of the CAM vessels. Hence, EA 9 was chosen as the optimal 
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B.2.  Egg temperature 
Short term temperature fluctuations were found to affect the consistency of the blood 
perfusion readings significantly (p value > 0.05) (Figure 12). Cooling was reported to 
decrease the rate of blood perfusion (Bornmyr et al., 2001). Further investigation 
therefore was carried out to improve measurement reproducibility by controlling the 
measurement temperature using an experimental setup that maintained the 
temperature of the egg during measurements. The egg was placed in a jacketted egg 
cup that was kept at a constant temperature by circulation of water from a 
temperature-controlled water bath. The temperature of the water bath was varied and 
the corresponding temperature of the egg cup was determined. The results showed a 
linear relationship which enabled control of the egg cup temperature by adjusting the 
temperature of the water bath (Figure 13). The temperature of the water bath had to be 
adjusted to 44ºC and the setup allowed to equilibrate for 2 h to obtain an egg cup 
temperature of 36 – 37ºC. An egg for experimentation was then removed from the 
incubator and placed immediately in the egg cup and allowed to equilibrate for 15 min 
before commencement of blood perfusion measurements. The normalized perfusion 
readings were found to be relatively constant with time (p value > 0.05), indicating 
that the constant temperature provided to the egg had enabled more consistent 
perfusion readings (Figure 12). Clearly, the specially fabricated egg cup was 
important for consistent perfusion measurement of the CAM using the LDPI 
equipment. 
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Figure 12. Blood perfusion readings of CAM (EA 9) over time with temperature 
control of 36 – 37 0C and without the use of temperature control (ambient, 26 – 30 0C) 
(n = 3) 
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Figure 13. The relationship between the temperature of the water bath and the 
temperature of the egg cup (n = 3) 
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C. Investigation of LDPI parameters on blood perfusion measurements 
using orthogonal array and partial factorial design  
The settings of the laser Doppler for CAM blood perfusion measuements were 
examined experimentally by statistical design studies. An orthogonal design study 
was carried out and amplitude was ranked as the variable of greatest influence (Tables 
7 and 8). The second most influential variable was found to be threshold, followed by 
distance and area of measurement. A second partial factorial study conducted found 
amplitude and threshold to be significant contributors to the perfusion measurements 
(p values < 0.05). However, no significant differences were observed for the different 
measurement and different distances between Doppler head and sample tested. Whilst 
the orthogonal array design and partial factorial studies were able to ascertain the 
more influential LDPI parameters, these studies were not able to determine the 
appropriate settings of each significant parameter for accurate measurement of blood 
perfusion. 
 
C.1. Univariate analysis 
A more detailed study was performed with different amplitude and threshold values to 
assess the extent of contribution of these variables to blood perfusion. Each of the 
LDPI parameters was evaluated one at a time by varying a specific parameter while 
keeping the other parameters constant. Area of measurement and distance of the 
sample from the Doppler head were also included in this analysis to confirm their 
non-significance. Perfusion measurements were made at the same location on the 
CAM for meaningful comparison and eggs of EA 9 were used. 
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Table 7. The L25 (54) Taguchi design matrix for influence of LDPI parameters on 
blood perfusion 
 
Variables  Outcome 
Expt 






1 0.00 0.00 0.00 0.00  0.00 0.00 
2 0.00 3.00 3.00 3.00  3.82 0.32 
3 0.00 5.00 5.00 5.00  6.81 0.59 
4 0.00 7.00 7.00 7.00  6.73 1.70 
5 0.00 10.00 10.00 10.00  0.00 0.00 
6 3.00 0.00 3.00 5.00  3.66 0.14 
7 3.00 3.00 5.00 7.00  4.19 1.75 
8 3.00 5.00 7.00 10.00  0.00 0.00 
9 3.00 7.00 10.00 3.00  9.93 0.03 
10 3.00 10.00 0.00 3.00  0.00 0.00 
11 5.00 0.00 5.00 10.00  0.00 0.00 
12 5.00 3.00 7.00 0.00  9.76 0.15 
13 5.00 5.00 10.00 3.00  9.99 0.01 
14 5.00 7.00 0.00 5.00  0.00 0.00 
15 5.00 10.00 3.00 7.00  7.10 1.81 
16 7.00 0.00 7.00 3.00  9.15 0.34 
17 7.00 3.00 10.00 5.00  9.80 0.11 
18 7.00 5.00 0.00 7.00  0.00 0.00 
19 7.00 7.00 3.00 10.00  0.00 0.00 
20 7.00 10.00 5.00 0.00  7.66 0.35 
21 10.00 0.00 10.00 7.00  2.00 2.00 
22 10.00 3.00 0.00 10.00  0.00 0.00 
23 10.00 5.00 3.00 0.00  5.02 0.62 
24 10.00 7.00 5.00 3.00  7.14 0.32 
25 10.00 10.00 7.00 5.00  9.42 0.12 
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Table 8. Influence of LDPI parameters investigated in accordance with an orthogonal   
array design 
Blood perfusion (V) 
 
Distance Area Amplitude Threshold 
K1 3.471 2.961 0.000 6.474 
K2 3.555 5.513 3.918 6.018 
K3 5.368 4.362 5.158 5.937 
K4 5.322 4.759 7.011 4.002 
K5 4.715 4.836 6.344 0.000 
RK 1.898 2.552 7.011 6.474 
 
K1, K2, K3, K4 and K5 refer to the average reading for each variable at levels 1, 2, 3, 4 
and 5 respectively. Rk refers to the range of K values for each variable, i.e. Kmax - Kmin 
 
 
C.2. Area of measurement 
Equivalent perfusion readings with comparable standard errors (Figure 14) were 
obtained for the 6 different measurement areas investigated. Statistical analysis of the 
data showed no significant differences (p > 0.05) among the readings, showing that 
the perfusion reading was not markedly affected by the size of the measurement area 
in the range chosen. Thus, an intermediate measurement area with the smallest width 
and medium length, 2 mm X 10 mm was chosen. 
 
C.3. Distance between sample and Doppler head 
The distance between sample and laser beam aperture located in the Doppler head 
was varied and it was found that a variation from 10 cm to 20 cm had insignificant 
effect on the perfusion readings (p <0.05). A study reported in the literature also 
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suggested that the distance between the test object and the Doppler head was best kept 
constant to eliminate variation of total quantity of reflected light which may 
contribute to random errors (Pemp et al., 2009). The amount of backscattered light, 
which is used to calculate the perfusion measurement may decrease with an increase 
in the distance from the sample to the Doppler head (Kernick and Shore, 2000). 
Hence, the Doppler head was kept at a constant distance of 11 cm away from the 
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Figure 15. Diagram of LDPI and egg cup illustrating distance between the Doppler 




Blood perfusion readings were found to increase linearly with the amplitude over the 
range of 0 to 10 (R2, 0.99). However, the standard error also increased proportionally. 
The same trend was observed for standard errors of the readings, indicating greater 
variation of blood perfusion with increased amplitude values. Thus, an amplitude of 1 
was chosen as the most reliable as it enabled a sensitive measurement with the lowest 
standard error value (Figure 16). The choice of amplitude setting coincided with the 
recommendation of the equipment manufacturer.  
 
Laser aperture encased within 
Doppler head 
 
CAM surface  
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Figure 16. Relationship between amplitude and blood perfusion of CAM (EA 9)  




Beyond threshold 7, the blood perfusion readings decreased markedly, and decreased 
to almost zero (Figure 17). Hence, threshold beyond 7 was deemed unsuitable for 
blood perfusion measurements. For a measurement, a high threshold was expected to 
be more sensitive and therefore a reasonably high threshold value of 6 was chosen for 
subsequent experiments. These optimization experiments were conducted using the 
CAM without the application of any test substance. A higher threshold would serve to 
adequately capture blood perfusion readings that may be increased or decreased on 
the addition of the test substance.  
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Figure 17. Relationship between threshold and blood perfusion of CAM (EA 9)  
(n = 3) 
 
C.6. Scanning speed and resolution  
The effects of scan speed and resolution were also studied in an attempt to elicit the 
sharpest image for measurement over the shortest possible scan time as a higher scan 
speed reduced the measurement time. The influence of scan speed and resolution on 
the resultant image data is depicted in Figure 18. A larger area of 16 mm x 16 mm 
using a human hand was employed to provide a clearer illustration of the effect of 
these two parameters on the resultant images and data. The use of high scan speed 
compromised the quality of the image obtained, leading to less reliable results(Figure 
18c). Thus, a low scan speed of 17 mm2 per second was selected. The measurement 
area covered when the resolution was set to low was greater than the area covered 
with a high resolution setting. However, a high resolution setting was necessary to 
produce sharp images of the test sample (Figure 18d – f).  
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(a)                                 
(b)                                 
(c)                                
(d)                                 
(e)                                
(f)                                 
Figure 18. Image data and corresponding photographs obtained with  (a) low scan 
speed, (b) medium scan speed, (c) high scan speed, (d) low resolution, (e) medium 
resolution and (f) high resolution
Image data 
       Photograph 
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From the different investigations carried out, it can be concluded that the partial 
deshelling method is more suitable than the full deshelling method for preparing the 
CAM for experimentation. The blood perfusion in the CAM can be measured by the 
LDPI method. Reliable measurements are possible with the use of fertilized eggs of 
appropriate age, proper control of egg temperature and LDPI parameter settings. 
 
D. Effects of test substances on tissue morphology & irritancy 
D.1. The CAM as a model for irritancy assessment 
The effects of photodynamic therapy on the CAM has been investigated (Gottfried et 
al., 1995). Damage to the CAM was quantified by the extent of haemostasis, clotting 
and haemorrhage. Clotting and haemorrhage have been previously defined (Methods - 
Section B.2). Haemostasis refers to the cessation of blood flow. The presence of 
haemostasis and clotting rendered the CAM as having undergone moderate damage, 
while extensive damage was depicted by the presence of widespread occlusion and 
haemorrhage. This method of assessment only focuses on the irritation effect but does 
not consider the time taken for the effect to be manifested. Since the latter is an 
important aspect of irritation potential, the aforementioned method may not be ideal.  
 
Irritancy assessment with the aid of the CAM was employed as a replacement to the 
Draize eye test in the late 1980s and early 1990s (Hjortsjo et al., 2009). In 1985, a 
time-dependent grading system was proposed for assessing irritancy using the CAM. 
In the measurement, the test substance was applied to the CAM surface, which was 
then examined for various effects, such as hyperemia, haemorrhage and clotting. A 
score was assigned to each effect. The score was time-dependent as it took into 
account the manifestation time of the effect. A test compound may cause more than 
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one irritation effect and its irriation potential was indicated by the cumulative score. 
The reaction of the CAM to irritants was compared to that of mucous membranes and 
found to be similar (Luepke, 1985). A contact period of 5 min after the instillation of 
the test substance had been proposed as being sufficient to reveal the irritation or toxic 
effects on the CAM (Tavaszi and Budai, 2007). The short reaction time needed allows 
for rapid assessment of irritancy.  
 
In this study, the CAM was employed to determine the irritation potential of various 
solvents and drugs. The findings would provide useful information for the selection of 
test substances and media for the subsequent perfusion studies (Table 9). No visible 
irritancy or changes in morphology were seen with deionized water, normal saline as 
well as 5% glucose monohydrate solution. The solvents selected are commonly used 
and not known to exert any adverse effect on the human body. The results of the 
irritancy assessment concurs with the above. No obvious signs of irritancy and/or 
toxicity were seen with propranolol at low concentrations, and theophylline, caffeine 
and GTN at all the concentrations tested. The above solvents and drugs were deemed 
as safe to use on the CAM at the tested concentrations. A more detailed discussion on 
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Table 9. Irritation potential of various solvents and drugs 
Effects observed 










-          0 
Normal 
saline 
0.9 % w/v          0 
5 % w/v 
glucose 
monohydrate 
5 % w/v 
         0 
Glycerin -    √       1* 
Propranolol 




0.83 mcg/ml – 
10 mg/ml 






15 mg/ml –  
60 mg/ml 





4 – 20 mg/ml          0 
GTN  1 mg/ml          0 
1 % v/v 
NMP 
1% v/v          0 
10 % v/v 
NMP 
10% v/v     √     5 
70 % v/v 
Ethanol 
70% v/v   √       1 
Glucagon 1 mg/ml          0 
Theophylline 0.17 – 7 mg/ml          0 
Nicotine 
0.013 & 0.023 
mg/ml 
  √   √   √ 9 
A: Manifestation time ≤ 0.5 min 
B: Manifestation time > 0.5 to 2 min 
C: Manifestation time > 2 to 5 min 
* Grading does not take into account embryotoxicity caused by glycerin  
# Average weight of the egg was found to be 60g and the amount of drug used was 
dosed according to the average weight of the egg 
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D.2. Propranolol 
At higher concentrations of propranolol applied, the tissue displayed evidences of 
clotting, hemorrhage and/or the presence of ghost vessels. Examples of haemorrhage 
and embryotoxicity are shown in Figure 19. Ghost vessels refer to vessels which were 
identifiable but devoid of blood flowing through them. The CAM also underwent 
hemostasis (Figure 20).  The propranolol concentration that caused vessel stasis was 
found to be close to the LD50 values reported for rats. LD50 refers to the medial lethal 
dose or lethal dose 50 %, which indicates the dose that kills 50 % of the animals 
tested. This suggests that the response of the CAM to toxicity could be akin to that of 
the rats, which are commonly employed as animal model in irritancy studies.  
 
     
Figure 19.  Example of (a) haemorrhage and (b) embryotoxicity 
 
Figure 20. Appearance of CAM (a) after the application of 30 mg/kg of propranolol 
and (b) after application of 7.5 mg/kg of propranolol.  
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D.3. 70% v/v Ethanol 
Minimal irritation effects in the form of very slight bleeding occurred on the CAM 
surface on application of the 70 % v/v ethanol. The bleeding response was not 
immediate and seen only after at least 15 minutes. This response was rather slow 
despite the use of a fairly high concentration of ethanol. Thus, ethanol was classified 
as having slight irriation potential according to the time-dependent scoring system. In 
the method used to prepare the CAM for experimentation, the surface of the egg was 
first disinfected with 70% ethanol. There is a possibility of ethanol permeation 
through the egg shell and it is reassuring to find that 70% ethanol has only slight 
irritation potential. The use of 70% ethanol as a solvent for perfusion studies may be 
considered acceptable.  
 
D.4. Glycerin 
The CAM showed vessel stasis over time with pure glycerin and the embryo was dead 
by the end of the hour. This finding indicated the embryotoxicity of glycerin. Glycerin 
was reported to cause blockage of the small vessels in the CAM. At concentration of 
90 % v/v, the main vessels of the CAM were damaged by blockage or coagulation 
(Forough et al., 2005). Glycerin was reported to cause embryotoxicity (Romanoff, 
1960). This could also account for the drop in blood perfusion seen after instillation of 
glycerin. The application of high concentrations of glycerin to the CAM should be 





 RESULTS AND DISCUSSION 
  82 
D.5. Nicotine 
Nicotine displayed signs of clotting, hyperaemia and vessel stasis at concentrations 
used in transdermal nicotine patches (Figure 21). Hyperemia was reported to occur in 
response to a reduction in blood flow to the tissue (Thorfinn et al., 2006). It was likely 
to be triggered by ischaemic stress due to reduced oxygen supply. The toxic effects of 
nicotine are known to occur mainly on the endothelium of the vascular system of 
humans (Czernin and Waldherr, 2003). Vessel stasis as a result of nicotine application 
has also been reported (Galanzha et al., 2007). According to the score obtained in this 
study, nicotine has strong irritation potential and is thus likely to affect the blood 
perfusion of the CAM.  
 
                                                     
          
    
Figure 21. Appearance of CAM (a) before the application of 4 µg of nicotine per egg, 
(b) after the application of 4µg of nicotine per egg, Vessel stasis was present. (c) 
before the application of 7 µg of nicotine per egg and (d) after application of 7 µg of 
nicotine per egg. Slight clotting and hyperaemia of the vessels occurred. 
(a) (b) 
(c) (d) 
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D.6.  NMP 
Irritancy to the CAM vasculature as evidenced by the signs of hemorrhage were 
displayed with 10 % v/v NMP but 1 % v/v NMP was relatively non-toxic. While 
NMP was known to enhance drug permeation, use of high concentrations of NMP 
was not recommended. These findings were supported by another study that found 
evidence of embryotoxicity of NMP in rat embryos from concentrations 
corresponding to greater than 4 % v/v NMP (Flick et al., 2009). Hence, the use of 
NMP should be minimised to concentrations lower than 10 % v/v when used as a 
solvent in conjunction with blood perfusion studies of the CAM. 
 
D.7. Effects of pH and osmolality of drug solutions on irritation of the CAM 
Osmotic agents have been reported to increase blood flow while extreme pH is known 
to be harmful to human and microbial cells (Ernest, 1980). It is not clear if pH and 
osmolality of the drug solution would cause any irritation to the CAM. Hence, the 
osmolality and pH of the different concentrations of propranolol, theophylline and 
caffeine solutions were determined (Table 10).  
 
An increase in drug concentration resulted in little change in pH but a significant 
increase in osmolality for both propranolol and theophylline. Since osmolality is a 
colligative property, an increase in concentration is expected to increase the 
osmolality of the solution. The pH values of the different drug concentrations lie 
within the slightly acidic range of 5.2 to 6.2. A mouse skin test to determine the 
irritant action of buffer solutions of different pH found that for isomolal conditions, 
skin irritation was seen with pH values less than 3 or more than 11 (Leighton et al., 
1985). Hence, the pH of the propranolol, theophylline and caffeine solutions are most 
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Table 10. pH and osmolality values of various drugs 
Drug Dose Concentration 
of test solution 
pH Osmolality 
(mmol/kg) 
 50 ng/ml 0.83 mcg/ml 6.1 318 
 100 ng/ml 1.67 mcg/ml 6.1 316 
 150 ng/ml 2.50 mcg/ml 6.1 319 
 200 ng/ml 3.33 mcg/ml 6.2 322 
Propranolol 250 ng/ml 4.17 mcg/ml 6.2 321 
 1 mg/kg 2 mg/ml 6.2 327 
 2 mg/kg 4 mg/ml 6.0 343 
 5 mg/kg 10 mg/ml 5.8 378 
 7.5 mg/kg 15 mg/ml 5.7 406 
 10 mg/kg 20 mg/ml 5.3 496 
 15 mg/kg 30 mg/ml 5.5 448 
 30 mg/kg 60 mg/ml 5.8 426 
 10 mcg/ml 0.17 mg/ml 5.8 313 
 20 mcg/ml 0.33 mg/ml 5.9 319 
 30 mcg/ml 0.50 mg/ml 5.9 322 
 40 mcg/ml 0.67 mg/ml 5.9 326 
 50 mcg/ml 0.83 mg/ml 5.8 329 
Theophylline 60 mcg/ml 1 mg/ml 5.8 331 
 1.5 mg/kg 3 mg/ml 5.5 334 
 2 mg/kg 6 mg/ml 5.5 338 
 2.5 mg/kg 5 mg/ml 5.3 339 
 3 mg/kg 6 mg/ml 5.3 340 
 3.5 mg/kg 7 mg/ml 5.2 348 
 2 mg/kg 4 mg/ml 5.6 335 
 4 mg/kg 8 mg/ml 5.6 346 
Caffeine 6 mg/kg 12 mg/ml 5.7 360 
 8 mg/kg 16 mg/ml 5.6 376 
 10 mg/kg 20 mg/ml 5.6 391 
30 µL of the respective concentrations was applied to the CAM to give the 
corresponding dose 
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unlikely to cause any irritation to the CAM. Another study investigated the effect of 
osmolality on irritancy using the HET-CAM method. The study reported that the 
cumulative irritancy score did not correlate with the osmolality values of the test 
substance, in the range of 195 to 2096 mmol/kg (Debbasch et al., 2005). Therefore, 
any irritation effects of the drug on the CAM was more likely to be attributed to the 
pharmacological action of the drug rather than the osmolality of its solution. 
 
E.  Blood perfusion studies 
From the earlier findings, perfusion studies were conducted using the following LDPI 
parameter settings for robust and accurate perfusion measurements: amplitude 1, 
threshold 6, scan area of 2 mm X 10 mm, distance between the Doppler head and 
CAM of 11 cm, low scanning speed of 17 mm s-1 and high resolution. The egg (EA 9) 
was allowed to equilibrate for 15 min in the temperature-controlled egg holder (37ºC) 
prior to subsequent study. 
 
Following the development of the CAM model, different types of drugs were 
employed to study the influence of drug concentration on blood perfusion (Table 2).  
These drugs were chosen as they were reported to exert vasodilation through different 
mechanisms of action. The types of receptors located in the CAM vessels are not well 
defined. Therefore, drugs with different mechanisms of action were evaluated to 
determine which would affect blood perfusion of the CAM. These drugs were also 
previously found to be safe to the CAM at the concentrations employed. Control 
experiments  were also performed using normal saline, deionized water and 5 % w/v 
glucose monohydrate solution. These solvents were employed to dissolve the drugs. 
Glycerin and 70 % v/v ethanol which were previously found to have similar irritation 
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potential, and NMP were also studied. The latter is known to be an effective 
permeation enhancer.  No appreciable changes in CAM blood perfusion in response to 
the application of normal saline, deionised water and 5 % w/v glucose monohydrate 
were found. Hence, these are suitable solvents that can be used in blood perfusion 
studies with the CAM. 
 
The magnitude of change in blood perfusion in response to the drug solution can be 
attributed to the absorption of the drug. 
 
E.1.  Indicators of vasoactivity 
The vasoactive effects of the test substance were sometimes difficult to compare 
based on their actual measurements due to variations in baseline values. Hence, a ratio 
was calculated which provided a more meaningful comparison. 
 
E.1.i.  Perfusion ratio 
Perfusion ratio was obtained by dividing the blood perfusion value of the test 
substance with the baseline blood perfusion value. Theoretically, a ratio greater than 1 
would indicate an increase in blood perfusion whilst a ratio lower than 1 would 
indicate a decrease in blood perfusion. The perfusion ratios obtained for the different 
concentrations of test substance are shown in Table 11. 
  
In general, changes in blood perfusion occurred 15 to 25 minutes after the application 
of the test substance and the change in blood perfusion lasted for about 10 min. 
Comparison of the change in blood perfusion was carried out by using the mean of the 
baseline perfusion values prior to the application of the test  
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Table 11. Perfusion ratio of test substances 
Test substance Concentration 
of test 
substance 





- 0.99 0.03 3.17 
Glucose 
monohydrate 
5 % w/v 0.98 0.04 3.30 
Deionised 
water 
- 1.04 0.04 3.38 
Normal saline 0.9 % w/v 
 
0.96 0.02 2.44 
4 mg/ml 1.00 0.04 3.97 
8 mg/ml 0.95 0.02 2.44 
12 mg/ml 0.92 0.02 1.74 




20 mg/ml 0.96 9.95 5.03 
0.016 mg/ml 0.76 0.03 3.42 
0.02 mg/ml 0.99 0.05 4.80 
0.04 mg/ml 0.84 0.03 3.71 
0.06 mg/ml 1.00 0.02 2.41 
0.1 mg/ml 0.94 0.02 2.59 
0.2 mg/ml 1.02 0.06 6.25 
0.3 mg/ml 0.93 0.04 4.81 






1 mg/ml 0.95 0.03 3.60 
 1 mg/kg 1.03 0.11 11.04 
 2mg/kg 1.12 0.14 13.73 
Propranolol 5 mg/kg 1.89 0.27 14.29 
 10 mg/kg 1.40 0.33 23.93 
 15 mg/kg 1.41 0.39 27.82 
NMP 1 % v/v 1.00 0.06 6.34 
Ethanol 70 % v/v 0.99 0.05 5.36 
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substance and comparing that with the mean of the perfusion values after the 
application of the test substance. 
 
The perfusion ratios of the controls were all very close to 1. However, blood perfusion 
in any biological system will be prone to fluctuations and biological variation, which 
explains some slight deviations. As such, the SE of the control was used to calculate a 
range of blood perfusion ratio values, i.e. mean of perfusion ratios for control ± 2SE.  
The range encompassed by 2SE shows the 95% confidence interval. Any test 
substance with blood perfusion ratio that occurred outside this range would be 
deemed to be able to cause a change in blood perfusion. Using this approach, the 
influence of normal biological fluctuation on blood perfusion changes was eliminated. 
No distinct relationship between the perfusion ratio and concentration of caffeine or 
GTN was observed. Most of the perfusion ratio values obtained are close to 1. The 
sensitivity of the perfusion ratio was rather low. This could be due to the degree of 
change of blood perfusion being small and thus, not resulting in any large appreciable 
changes.  
 
E.1.ii.  Diameter ratio 
Diameter ratio was obtained by dividing the vessel diameter value with the baseline 
vessel diameter value. Changes in vessel diameter were seen almost instantaneously 
or 5 – 10 min after the application of drug. The diameter ratios are shown in Table 12. 
The vasoconstriction seen with ethanol was reflected in its distinctly lower diameter 
ratio. The vasodilation effect exerted by caffeine and GTN was indicated by diameter 
ratio values that were greater than 1. Comparison of change in vessel diameter was 
done by obtaining the mean of the baseline vessel diameter values prior to the  
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Table 12. Diameter ratio of test substances 
Test substance Concentration 
of test 
substance 





- 0.99 0.02 2.34 
Glucose 
monohydrate 
5 % w/v 1.02 0.03 2.54 
Deionised 
water 
- 0.96 0.01 0.81 
Normal saline 0.9 % w/v 1.00 0.01 0.64 
4 mg/ml 1.10 0.07 6.48 
8 mg/ml 1.14 0.07 6.44 
12 mg/ml 1.18 0.06 4.63 




20 mg/ml 1.42 0.21 14.99 
0.016 mg/ml 1.06 0.02 1.51 
0.02 mg/ml 1.06 0.05 4.77 
0.04 mg/ml 1.08 0.03 2.97 
0.06 mg/ml 1.05 0.07 7.08 
0.1 mg/ml 1.25 0.11 8.99 
0.2 mg/ml 1.03 0.04 4.14 
0.3 mg/ml 1.01 0.08 8.36 






1 mg/ml 1.11 0.09 7.86 
NMP 1 % v/v 0.96 0.03 3.14 
Ethanol 70 % v/v 0.77 0.11 14.81 
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application of the test substance and comparing that with the mean of the vessel 
diameter values that showed a change after the application of the test substance. 
 
Similarly, a range of diameter ratio values, i.e. mean of diameter ratio for control ± 
2SE was calculated and used as a benchmark to assess if the test substances caused 
any change to the vessel size. Any test substance with diameter ratio outside this 
range would be deemed to be able to cause a change in the vessel diameter. The 
perfusion ratio and the diameter ratio of different concentrations of the same test 
compound were compared. The spread of the diameter ratio was much larger than that 
of perfusion ratio for caffeine but comparable for GTN. This suggests that diameter 
ratio is a more sensitive indicator of vasoactivity than perfusion ratio. 
 
A more detailed discussion on the the effects of the various test substances is given 
below. For ease of comparison, the baseline mean ratio and ± 2SE values are included 
with all the relevant graphs. The former is indicated by a continuous line while the 
latter by 2 parallel dotted lines. 
 
E.2.  Controls 
Blood perfusion studies were first conducted on the CAM without the application of 
any substance, drug or solvent, to assess the baseline blood perfusion pattern of the 
CAM. Blood perfusion was found to remain relatively constant without any marked 
fluctuations over time. Consistent blood perfusion values were also seen after 
instillation of the solvent used to prepare the drug solution for test. The solutions used 
were water, normal saline and 5 % w/v glucose monohydrate in water. The above 
observation for normal saline concurs with the absence of irritation to the CAM by 
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normal saline, as reported by other researchers (Hjortsjo et al., 2009). A typical plot of 
the blood perfusion ratio over time for the aforementioned solvents is shown in Figure 
22. The blood perfusion profile showed a very slight sinusoidal pattern which is 
similar to that of the baseline blood perfusion without any solvent or drug. Thus, it 
could be deduced that the solvents did not cause any significant change to the blood 
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Figure 22. Change in blood perfusion ratio with time following the addition of 5 % 
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E.3.  Glycerin 
The blood perfusion profile showed a significant drop in blood perfusion rate 
immediately after the addition of glycerin, followed by fluctuation within the baseline 
blood perfusion range and then a significant drop after about 11 min (Figure 23). 
Glycerin required an incubation period of at least 10 min for its vasoactive property to 
manifest. The depression in blood perfusion lasted for at least 20 min after the onset 
of change in blood perfusion, without recovery to baseline level within the duration of 
the study.  
 
High concentrations of glycerin was reported to cause a reduction in blood flow of the 
CAM (Forough et al., 2005). The results in this study further show that glycerin 
exerted a prolonged vasoactive effect on the CAM vasculature and the CAM was 
unable to re-establish the baseline blood perfusion level within 30 min. It should be 
recalled that glycerin was previously found to be harmful to the CAM in the irritancy 
assessment. The embryo died by the end of the hour after the administration of 
glycerin. Blood perfusion rate had clearly shown deviation from the baseline blood 
perfusion value. Therefore, glycerin is harmful and has the potential to reduce blood 
perfusion of the CAM and it would not be a suitable to be used in the evaluation of 
drug vasoactivity. 
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Figure 23. Relationship of blood perfusion ratio with time with 100% glycerin 
solution added at 0 min (n = 5) 
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E.4.  Glucagon and Menthol 
The solubility of menthol in water is extremely poor. Application of heat to increase 
the aqueous solubility of menthol is not recommended as menthol is volatile. Hence, 
liquid paraffin was used as a vehicle to dissolve menthol. Instillation of liquid paraffin 
was previously found to have no appreciable effect on blood perfusion. The effects of 
0.1 % w/v glucagon and 2 % w/v menthol on blood perfusion of the CAM were 
evaluated (Figures 24 and 25). These concentrations are reflective of doses used in 
many pharmaceutical external medicaments. The application of these two test 
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Figure 24. Effect of 2 % w/v menthol on blood perfusion of the CAM (n = 5) 
 
 
 RESULTS AND DISCUSSION 





















   
.
 
Figure 25. Effect of 0.1 % w/v glucagon solution on blood perfusion of the CAM (n = 
5) 
 
slight sinusoidal blood perfusion pattern, similar to that of the baseline blood 
perfusion was seen. The sinusoidal pattern appeared slightly more exaggerated with 
menthol. This could be attributed to the physical sensation of coolness often 
associated with menthol. Both glucagon and menthol have been reported to exert 
vasodilative effect and increase blood flow (Brain et al., 2006, Farah, 1983). 
However, no effect on CAM blood perfusion was seen, possibly indicating the 
absence of the receptors associated with glucagon and menthol. Information on the 
menthol and glucagon receptors responsible for vasodilation is not readily available, 
however, it has been postulated that the glucagon receptors affect cAMP levels to 
induce vasodilation (Farah, 1983). Another possible reason for the limited effect of 
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glucagon and menthol may be their high affinity for liquid paraffin, and very small 
amounts of either test substances were available to act on the CAM. 
 
E.5.  Ethanol 
Ethanol has been reported to be capable of causing both vasoconstriction and 
vasodilation (Nicoletti et al., 2008, Yogi et al., 2010). Its effect on blood perfusion of 
the CAM has not been reported. The investigation on the effect of 70 % v/v ethanol 
served two purposes in this study. Firstly, the influence of 70 % v/v ethanol on the 
vasculature when it was used as a solvent can be taken into account during data 
analysis. Secondly, in the disinfection of the eggs before experimentation, 70 % v/v 
ethanol was applied to the eggs’ surface. The egg shell is proprosed to possess pores 
which allow the loss of water as well as gaseous exchange (Rahn et al., 1987). 
Clearly, the disinfection process may potentially result in 70 % v/v ethanol being 
absorbed through the shell. It is important to know if this would affect the perfusion 
study of drug substances. In this study, ethanol at a concentration of 70 % v/v in water 
was instilled on the surface of the CAM. The effect of 70 % v/v ethanol on the CAM 
is shown in Figure 26. Close examination of the blood perfusion profile shows an 
interesting pattern. Immediately after the application of 70 % v/v ethanol, blood 
perfusion increased. Fluctuation in blood perfusion was observed but it remained 
above the baseline. After 12 min, blood perfusion decreased to a level below the 
baseline. About 20 min after the application of 70 % v/v alcohol, the blood perfusion 
returned to its baseline value. Overall, the values of the blood perfusion generally lie 
within the baseline range, indicating that 70 % v/v ethanol exerted little and short-
lived effect on the blood perfusion. The use of 70 % v/v ethanol to disinfect the eggs 
is therefore unlikely to affect the perfusion studies. 
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Figure 26. Effect of 70% ethanol on blood perfusion of the CAM (n = 5) 
 
The accentuated cyclic trend, in which blood perfusion increased or decreased 
alternatively, indicated the existence of an auto-regulation mechanism in response to 
the initial increase stimulus in blood perfusion. Compensation for the initial increase 
in blood perfusion resulted in a decrease in blood perfusion before achieving baseline 
blood perfusion level once again. This study demonstrated that ethanol exerted an 
immediate effect on blood perfusion in the CAM and the effect was curbed by an 
auto-regulation mechanism. Such mechanisms, which may involve a host of 
biological factors, have been reported in humans where they play important roles in 
maintaining a stable system known as homeostasis (Guyton, 2000). 
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It was also possible that ethanol exhibited dual vasoconstrictive and vasodilative 
effects in the CAM.  Ethanol first exerted a vasodilative effect on the CAM vessels, 
resulting in an increase in blood perfusion rate. High concentrations of ethanol had 
been found in another study to cause vasoconstriction, potentially through a redox 
sensitive and cyclo-oxygenase dependent pathways that affected the production of 
reactive oxygen species and Ca2+ signaling (Yogi et al., 2010). Hence, as more 
ethanol reached the CAM vessels over time, the receptors that caused vasoconstriction 
were possibly overactivated, resulting in the decrease in blood perfusion henceforth. 
Extrapolating from here, the diameters of the CAM vessels under the influence of 
70% ethanol were further investigated and discussed in Section F.3. When used as a 
solvent, ethanol has the potential to trigger the auto-regulation mechanism or cause 
vasodilation and vasoconstriction. Thus, it is not an ideal solvent to be used in the 
perfusion study of drug substances. 
 
E.6.  N-Methyl-2-Pyrrolidone 
The effect of NMP was also evaluated as it has been demonstrated to be a good 
permeation enhancer (Saw et al., 2005a, Saw et al., 2005b). Two concentrations of 
NMP (1 % w/v and 10 % w/v), were tested. A very distinct drop in blood perfusion 
was seen with 10 % v/v NMP but insignificant effect by 1 % v/v NMP were observed 
(Figure 27). The effect was seen immediately after application of 10 % v/v NMP. 
Blood perfusion decreased gradually over time and reached the minima around 10 
min after application of NMP. Blood perfusion hovered at the low level for about 10 
min before gradually recovering after the 20th min time point, in a bid to re-establish 
the baseline blood perfusion albeit at a slightly lower level. The results illustrate that 
the permeation of NMP through the CAM was dependent on concentration. The effect 
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Figure 27.  Effect of 1 % and 10 % v/v NMP solution on blood perfusion of the CAM 
(n = 5) 
 
E.7.  Propranolol 
Propranolol is a β-blocker that affects both the ß1 and ß2 adrenoceptors. Resultant 
decrease in blood pressure in human subjects had been attributed to the reduction in 
cardiac output and decreased peripheral vascular resistance brought about by the 
action of propranolol. It was also found to act on the peripheral presynaptic 
adrenoceptors to decrease sympathetic vasoconstrictor nerve activity (Katzung, 2001). 
It is not known if ß1 and ß2 adrenoceptors are found in the chick embryo and whether 
propranolol would affect the function of the CAM. Experiments were therefore 
conducted to determine the effects of different concentrations of propranolol on blood 
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perfusion of the CAM. Three different doses of propranolol, 7.5, 15 and 30 mg/kg, 
were used in the first set of experiments. The highest dose is close to the LD50 in rats 
whilst the lowest dose is close to the high doses used in pediatrics (Lacy et al., 2004). 
The average weight of over 300 eggs was found to be 61.3g ± 4.1 g. This was rounded 
off to 60 g and used for the calculation of the amount of propranolol to be applied to 
the CAM. A slight increase in blood perfusion was seen when propranolol was 
administered, followed by a decrease in blood perfusion. The CAM tissues were also 
found to undergo hemorrhage and the embryo died about an hour after drug 
application.  
 
As observed in the earlier irritancy assessment, propranolol in the dose range of 7.5 to 
30 mg/kg was harmful to the CAM. From this perfusion study, it was further shown 
that propranolol was capable of increasing blood perfusion in the CAM, albeit a slight 
increase. The blood perfusion in the CAM gradually decreased despite the high dose, 
probably due to the harmful effects of the drug on the embryo.  
 
It was thought that dosing propranolol by weight of the egg based on human doses 
might have resulted in harmful doses to the chick embryo. Hence, the amount of 
propranolol applied was recalculated, taking into account the total blood volume 
rather than weight of the egg. The total blood volume of the egg was reported to be 
513 mm3, which corresponds to about 0.5 mL (Kind, 1975). Further experiments were 
carried out with lower doses of propranolol, ranging from 50 ng/mL to 100 ng/mL 
which correspond to the therapeutic concentrations in human blood in hypertension 
management. Perfusion measurement intervals were shortened to 2 min over the 
duration of an hour after the application of propranolol. Surprisingly, a transient drop 
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in blood perfusion was seen after these lower doses of propranolol were applied to the 
CAM, followed by a small increase. Higher doses of propranolol of 150, 200 and 250 
ng/mL were further tested and found to have insignificant effect on the blood 
perfusion. Response of the CAM blood perfusion to propranolol appeared complex.  
 
In subsequent experiments, the test doses of propranolol were re-adjusted based on 
egg weight, covering a wide range that included 1, 2, 5, 10 and 15 mg/kg. With the 
dose of 1 mg/kg, there was only a slight increase in blood perfusion, followed by a 
very gradual decrease in blood perfusion with time. The other propranolol doses of 2 
mg/kg and 5 mg/kg also showed similar trends. In contrast, the higher doses of 10 
mg/kg and 15 mg/kg caused haemorrhage and the embryos died about an hour after 
the application of the drug. This confirmed the earlier observations for similar 
propranolol doses. 
 
A plot of the blood perfusion ratio versus the concentration of propranolol used is 
shown in Figure 28. All of the propranolol doses caused an increase in blood 
perfusion. The extent of this increase reaches a maximum at the dose of 5 mg/kg, after 
which the magnitude of increase in blood perfusion drops. However, at these high 
concentrations, the change seen in blood perfusion might be complicated by their 
harmful effects to the CAM.  
 
This is an interesting finding as propranolol had been reported to decrease peripheral 
vascular resistance in humans. It should therefore be inferred that the receptors found 
in the CAM are significantly different and less sensitive to propranolol. Due to the 
complexity and potential toxicity of propranolol, the use of propranolol as a marker 
drug for the assessment of blood perfusion may not be ideal. A marker drug should 
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not be toxic to the embryo and should preferably display reproducible change in blood 
perfusion that can be used to provide an accurate estimate of the influence of other 
variables on the absorption of the vasoactive marker drug. 
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Figure 28. The relationship between blood perfusion ratio and propranolol dose (n = 
3) 
 
E.8.  Theophylline 
Theophylline, a methylxanthine bronchodilator, produces bronchodilation in human 
subjects through the inhibition of phosphodiesterase in the smooth muscle of the 
airway. The methylxanthines induce peripheral vasodilation. It was also reported to 
dilate coronary blood vessels (Bath, 2004). In addition, it stimulated the central 
nervous system by antagonizing adenosine and also produced cerebral 
vasoconstriction leading to a reduction in cerebral blood perfusion (Nehlig et al., 
1992). It was employed for the treatment of ischemic stroke to produce cerebral 
vasoconstriction and increase blood perfusion to non-ischemic areas in the brain 
whilst increasing collateral blood perfusion to the ischemic region. The effect of 
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theophylline on the CAM has not been reported. Doses in the range of, 10, 20, 30, 40, 
50, and 60 mcg/mL were tested. Blood perfusion readings were taken every minute 
for 25 min to capture any instantaneous change in blood perfusion. Readings were 
also taken at the 1st, 2nd, 3rd and 4th hour since theophylline concentration was 
previously found to reach a peak one to two hours after oral ingestion in humans 
(Lacy et al., 2004). Slight change in blood perfusion over time was observed with the 
theophylline doses used. However, the extent of change in blood perfusion was much 
smaller compared to propranolol and most likely, the measurements were of little 
clinical relevance to describe the drug’s mode of action. 
 
Further studies were carried out to investigate the influence of higher theophylline 
doses. The doses tested were equivalent to those recommended for pediatrics, 3.5, 3, 
2.5, 2 and 1.5 mg/kg (Lacy et al., 2004). There did not appear to be any distinct 
relationship between the theophylline dose and blood perfusion. Theophylline did not 
demonstrate any substantial perfusion changes upon application. The lack of 
significant effect could possibly be due to the requirement of metabolic 
transformation of theophylline before exerting vasoactive methylxanthine effect 
(Bath, 2004). The metabolism of theophylline would result in the formation of 
metabolites such as caffeine. Hence, a further study was undertaken to establish if the 
CAM was more responsive to caffeine. 
 
E.9.  Caffeine 
Vasodilation has been purported to be effected by increased cyclic adenosine 
monophosphate, inhibition of Ca2+ influx and inhibition of phosphodiesterase in 
humans. The binding of adenosine to adenosine receptors was found to cause 
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vasodilation (Lapeyre et al., 2004). Caffeine is a methylxanthine. It has been reported 
to exert competitive inhibition of adenosine binding to adenosine receptors, thereby 
causing vasoconstriction (Addicott et al., 2009). The effect of caffeine on the blood 
vessels of the CAM has not been reported. Vasoconstriction is expected to result in a 
decrease in blood perfusion. Hence, a decrease in blood perfusion with caffeine would 
suggest that caffeine causes constriction of blood vessels in the CAM.  
 
The caffeine doses used in this study were 2, 4, 6, 8 and 10 mg/kg. These doses were 
chosen as they encompass the doses given to adults and children to treat various 
medical conditions. The choice of test dose also took into account the solubility of 
caffeine in normal saline. Blood perfusion in the CAM vessels was found to decrease 
in response to application of caffeine on the CAM surface. This suggests that caffeine 
exerted vasoconstrictive effect on the CAM vessels, similar to human vessels. The 
blood perfusion ratio with 6 mg/kg and 10 mg/kg of caffeine is shown in Figure 29.  
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Figure 29. Change in blood perfusion with 6 mg/kg and 10 mg/kg of caffeine added at 
0 min (n = 5) 
 
A ratio of less than 1 indicates a drop in blood perfusion and a ratio greater than 1 
indicates an increase in blood perfusion. The consistent ratio of value below 1 
confirms that a drop in blood perfusion occurs with caffeine. Blood perfusion was 
found to decrease almost immediately after the administration of 6 mg/kg caffeine. 
This trend was also seen with the 2, 4, 8 and 10 mg/kg treatment groups. The blood 
perfusion levels started to rise toward the baseline level again after 30 - 35 min. 
Overall, the trend observed in changes in blood perfusion with respect to the baseline 
blood perfusion was consistent.  
 
The degree of change in blood perfusion was higher than that seen with theophylline. 
These results were also comparable to the change in blood flow seen in humans in 
LDPI studies conducted with vasoconstrictive topical corticosteroids (Sommer et al., 
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2003). Therefore, further analysis of the data was conducted, whereby the absolute 
decrease in blood perfusion was plotted against caffeine dose. This was done by 
obtaining the mean of the perfusion values prior to caffeine application and 
comparing that with the mean of the perfusion values that showed a decrease after 
caffeine application. The percentage change in blood perfusion was then plotted 
against the caffeine dose to eliminate the variability in baseline blood perfusion of the 
different eggs used (Figure 30). The relationship found was not straightforward. 
According to the Pearson’s correlation test, it is non-linear (p > 0.05) and best 
described by a curve that initially appears linear before gradually attaining a plateau 
status toward the end of the curve. The magnitude of decrease in blood perfusion 
seemed to increase linearly from 2 mg/kg to 6 mg/kg of caffeine. Caffeine in 
concentrations beyond 6 mg/kg resulted in a gradual plateau in the graph. The 
presence of such a trend further illustrated the complicated effect of caffeine on the 
CAM blood perfusion. The effect of caffeine on vessel diameter is discussed in 
Section F.6. 
 
The relationship of percentage change in blood perfusion with caffeine dose 
resembles the typical threshold model where the change in response reaches a maxima 
before leveling out. In the case of caffeine, the maxima is reached at the 10 mg/kg 
concentration point. Besides caffeine, other drugs such as pentobarbital and cocaine 
have been reported to display similar dose responses in pigeons and monkeys 
(Spealman et al., 1977). 
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Figure 30. Relationship between caffeine concentration and change in blood perfusion 
(n = 5) 
 
E.10.  GTN 
GTN is part of the nitrate family that releases nitric oxide in human vascular smooth 
muscle. Nitric oxide is a powerful vasodilator which elicits a rapid response from 
large arteries and veins. Venodilation, arterial-arteriolar dilation as well as dilation of 
vessels in the heart occur in the presence of GTN (Kelly et al., 2005). Veins are more 
sensitive than arteries to nitric oxide whilst arterioles are the least sensitive (Katzung, 
2001). Owing to import restrictions, pure GTN was not available for this study. Two 
different types of GTN were used to investigate if the results were affected by the 
presence of formulation additives added to the GTN tablets as opposed to the GTN in 
injection form. 
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E.10.i.  Tablet dosage form 
GTN tablets were appropriately dissolved and diluted in normal saline to prepare the 
test solutions. Low doses of GTN were initially employed to determine the ability of 
GTN to elicit any vasoactive effects on the CAM model. Doses tested were 0.01, 
0.0125, 0.025, 0.0375, 0.05, 0.075, 0.1, 0.12, 0.15, 0.2 and 0.25 mg/kg of the egg. 
These doses are close to the clinically used sublingual doses (Cossum and Roberts, 
1985). Blood perfusion was found to decrease immediately after the application of 
GTN and this could be due to the reactive response of the CAM to the drug. The 
perfusion values before and after application of GTN were compared. The depression 
of blood perfusion in the CAM was seen to last for at least 15 min before blood 
perfusion level returned to the baseline (Figure 31). Blood perfusion was expected to 
increase following vasodilation with GTN, as vessel resistance is decreased and 
hence, blood perfusion enhanced. However, a decrease in blood perfusion after the 
application of GTN was observed in the majority of the concentrations used. A study 
using optical Doppler tomography to monitor blood perfusion in the CAM showed an 
increase in blood perfusion in the CAM arteries and a decrease in CAM veins 
following application of GTN (Chen et al., 1998). GTN resulted in dilation of both 
arteries and veins, and decreased the blood flow in arteries but increased the blood 
flow in veins. The mechanism behind this differing response to GTN is unknown. 
Arteries and veins can be distinguished by observing the direction of blood flow in the 
vessels with a stereo dissecting microscope (Fuchs and Lindenbaum, 1988, Shumko et 
al., 1988). On closer examination, the vessels measured were found to be brighter red 
in colour, suggesting that they were veins. CAM veins are equivalent to the 
pulmonary veins in humans. They bring oxygenated blood back to the embryo and 
would hence deliver blood that is brighter than those carried by the CAM arteries.  
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Figure 31. Blood perfusion ratios after application of GTN at time 0 min at dose of 
0.25 mg/kg (n = 5) 
 
This observation, coupled with the decrease in blood perfusion suggested that 
majority of the vessels measured were probably veins. This was further investigated 
and discussed in Section E.10.iii. The findings highlighted the significance of 
identifying whether the vessel measured was a vein or artery. It also showed that the 
CAM studied had more predominant veins than arteries. 
 
In this study, blood perfusion decreased with all the GTN doses employed. The 
relationship was however not straightforward and it was of interest to determine a 
simple mathematical model that best describes the relationship. Hence, the data was 
further analyzed by plotting the GTN doses with the various derivatives of perfusion, 
i.e. perfusion change, percentage or log perfusion change and square root of perfusion 
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change. Except for the plots of GTN doses versus the square or square root of 
perfusion change, sine wave relationships were noted. Sine waves were also seen in 
the plot of the change in vessel diameter against GTN dose. This suggested that the 
manner by which GTN interacted with the relevant receptors was complex and/or 
compensatory mechanisms existed in response to GTN.  
 
The plot of the square root of perfusion change versus GTN dose in the range of 0.01 
mg/kg to 0.05 mg/kg showed a linear relationship with an R2 value of 0.99 (Figure 
32). Any subtle change in GTN dose within this range would be manifested by a 
proportional change in blood perfusion of the CAM. Hence, the effect of a 
formulation factor that result in a decrease or increase in GTN absorption within this 
range can be quantified. An estimation of the effect can be deduced from the change 
in blood perfusion. Although a wider concentration range is desirable, the 5-fold 
difference in concentration obtained for GTN is useful for evaluating the influence of 
formulation factors on drug absorption. The presence of various excipients in GTN 
tablets could have served as a confounding factor in the above study. Hence, the 
investigation was extended to include GTN injections to address this. 
 
E.10.ii. Injection dosage form 
GTN was diluted from a stock vial of GTN injection that consisted of GTN at a 
concentration of 1 mg/mL. This was carried out to determine if the presence of the 
excipients in the GTN sublingual tablet had any significant effect on blood perfusion. 
The doses tested were 0.01, 0.03, 0.05, 0.1, 0.15, 0.2 and 0.5 mg/kg of the egg weight, 
to correspond with the doses prepared from the GTN tablets (Figure 33). The trend 
obtained using the GTN injection was different (Figures 32 and 34), suggesting that 
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the excipients either in the GTN tablet or injection had affected the vasoactive effects 
of GTN on the CAM. As formulations of injections are generally simpler, it is most 
likely that interacting excipients are with the tablet dosage forms. 
 
Another possible reason for these differing results could be due to the biphasic 
relaxant effect that had resulted from the action of GTN. It was proposed that 2 
mechanisms of action existed for the biphasic response of GTN and that the 
metabolites of GTN also had an influence (Malta, 1989a, Malta, 1989b). However, 
there was little information with regard to this biphasic proposal, and is not readily 
available. However, the findings of this study suggested biphasic behaviour.  
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Figure 32.  Relationship between square root of percentage change in blood perfusion 
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Figure 34. Effect of GTN dose on blood perfusion using GTN injection (n = 5) 
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E.10.iii. Blood perfusion in CAM veins and CAM arteries 
Attempts were made to differentiate the veins from the arteries by their appearance. 
The blood perfusion in the respective veins and arteries in reponse to the different 
GTN doses was then determined (Figure 35).   
 
The CAM arteries displayed vasodilation in response to GTN, as indicated by their 
greater blood perfusion with respect to the baseline. The reverse was exhibited by the 
CAM veins, indicating vasoconstriction. As most of the vessels measured previously 
were veins, an overall reduction in blood perfusion was obtained. The change in blood 
perfusion in the arteries was slightly increased by increasing GTN dose. Interestingly, 










































Figure 35. Relationship between GTN dose and blood perfusion change in CAM 
veins and arteries (n = 5) 
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effect was markedly greater. Such complexities in response of the blood vessels to 
GTN suggest the involvement of multiple factors and auto-regulation mechanisms. 
 
E.11.  Auto-regulation of blood perfusion 
The results seen with caffeine and GTN indicated the existence of auto-regulation of 
blood perfusion by the CAM. Auto-regulation is an extremely complex array of 
mechanotransduction pathways (Olufsen et al., 2005, Sankaranarayanan et al., 2006). 
Blood perfusion has often been regarded as a crucial modulator of vascular tone. 
Combined effects of myogenic and metabolic regulation in response to the changes in 
blood flow have been reported (Carlson et al., 2008). In human skin, perfusion 
changes are dealt with by the action of reflex neural control. An increase in skin blood 
perfusion would result in the activation of sympathetic vasoconstrictor nerves and a 
decrease in skin blood perfusion would result in the activation of vasodilator nerves 
(Charkoudian, 2003). It has been postulated that this results from a process known as 
mechanoreception whereby the presence of mechanosensors located in endothelium 
would be triggered accordingly to result in either the release of hormones or various 
endothelium-derived relaxing and contracting factors (Rubanyi et al., 1990, Price, 
1991). Other proposed mechanotransducers include ion channels, integrins, 
heterotrimeric G proteins and various others, although their mechanisms of action 
remain elusive (Hahn and Schwartz, 2009). Myogenic auto-regulation involves the 
vasoconstriction and vasodilation of the vessel to bring about an increase and decrease 
in resistance respectively. Metabolic regulation would result in the release of signal 
molecules to cause vasodilation and vasoconstriction accordingly. This would cause 
blood flow to change in accordance to the situation. It has been reported that the 
arteries in the CAM in the early stages of embryonic development adapt to the size of 
 RESULTS AND DISCUSSION 
  116 
their lumen in response to the blood that flows through in order to maintain mean 
shear stress at a constant level (Le Noble et al., 2005). Thus, in the CAM, changes in 
blood perfusion are also met with auto-regulation responses. Shear stress is related to 
both vessel diameter and the rate of blood flow. When the diameter of the vessel 
changes, blood perfusion would change and so would shear stress in response to 
blood perfusion changes. The changes in shear stress would then spark the regulation 
of vessel diameters to combat this change (Stasi et al., 2010). At higher concentrations 
of caffeine, the change in blood perfusion could have sparked a chain reaction in the 
CAM, resulting in a smaller extent of increase in blood perfusion compared to lower 
concentrations. As for the case of GTN, auto-regulation could have set in from the 
initial concentrations, but the combination of receptors’ effects could have over ridden 
the auto-regulation effect, resulting in the decrease in the drop in blood perfusion at 
higher concentrations. 
 
According to Poiseuille’s Law, volume flow rate is directly proportional to the 
diameter of the tube, to the power of 4  as shown in Equation 4 (Silverthorn, 2001). 









=                                       Equation 4 
 
where  Q = volume flow rate, p = driving pressure, r = radius of the tube, η = fluid 
viscosity and L = vessel length 
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The impact of changing the diameter of blood vessels on perfusion may also be 







=                                       Equation 5 
 
where  R = resistance to blood flow. 
 
An increase in diameter reduces the resistance to blood flow in the vessel. The 
reduction in resistance to flow would result in an increase in blood perfusion. Hence, 
an increase in diameter would increase blood perfusion. 
 
Drugs that cause vasodilation could theoretically bring about an increase in blood 
flow. Poiseuille’s law strictly applies to homogeneous fluids that do not have shear 
dependent changes in viscosity, move through a rigid tube and display non-pulsatile 
flow. This cannot be directly applied to the CAM, where blood flow occurs in a 
pulsatile manner through vessel walls that contain vascular smooth muscles that are 
capable of altering the vessel diameters and modifying blood flow rate. However, this 
law is still applicable to situations with pulsatile flow where mean flow rate does not 
change. As the results obtained did not show the theoretical trend, it was postulated 
that the auto-regulation of the CAM moderated the increase in blood perfusion by 
causing the blood perfusion to decrease in an over-compensatory manner.  
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F.  Imaging studies 
F.1.  Effect of test substances on vessel size 
The test substance was applied on the surface of the CAM and images captured at 
regular time intervals. The images captured were then analysed with a software to 
determine the vessel diameters (Figure 36). Different segments in a selected area for 
measurement were identified. The respective diameters of each vessel portion located 
in different segments were identified using the software. Using this procedure, the 
diameter of a specific vessel was determined automatically at each time point for the 
respective drug concentration. The change in vessel diameter for each concentration 
tested was then plotted to determine the concentration effect. This was done to 
illustrate the relationship between vessel diameter and blood perfusion, as well as to 




The distribution of the vessel diameter of the CAM was found to be normal (p > 0.05) 
according to the Kolmogorov-Smirnov test. Baseline changes in vessel diameter, i.e. 
control without the application of test substance were monitored over time. From the 
results obtained, it was apparent that the vessel diameters of the CAM at rest did not 
change significantly over time (Figure 37). Therefore, any change in vessel diameter 
seen in subsequent studies would most likely be attributed to the vasoactive effect of 
the test substance. Nevertheless, some small functions in blood vessel diameters were 
seen over time but these small fluctuations were relatively small and within a small 
range. 
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Figure 37. Vessel diameter of CAM over time (control) (n = 5) 
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F.3.  70 % v/v ethanol 
Ethanol at concentration of 70 % v/v is commonly used as a solvent for drugs. 
Ethanol was reported to possess transdermal penetration enhancing action (Sinha and 
Kaur, 2000). Low doses of ethanol were found to increase the release of nitric oxide 
from the endothelium and hence augment vasodilation but high doses impaired 
relaxation of the endothelium (Puddey et al., 2001). Ethanol has been reported to 
cause both vasoconstriction (Altura et al., 1983, Yong et al., 1992, Zhang et al., 1993) 
and vasodilation (Altura et al., 1979, Mayhan and Didion, 1995).  
 
The results show an immediate decrease in vessel diameter, followed by prolonged 
vasoconstriction in response to the ethanol administered (Figure 38). In an earlier 
study, blood perfusion increased immediately after the application of 70 % v/v 
ethanol, coinciding with the increase in vessel diameter. The subsequent 
vasoconstrictive effect of 70% ethanol lasted for at least an hour, occurring in tandem 
with reduced blood perfusion. In accordance with Poiseulle’s Law, changes in vessel 
diameters had affected blood perfusion. As such, vessel diameters change would be 
the primary factor to ascertain if there was any vasoactive activity occurring in 
response to an external stimulus on the CAM vessels and changes in blood perfusion 
would hence be the secondary factor that had occurred as a result of changes in CAM 
vessel diameter values. 
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Figure 38. Effect of 70% ethanol on CAM vessel diameter when added at time 0 min 
(n = 5) 
 
F.4.  NMP 
The change in vessel diameter with 10 % v/v NMP could not be further investigated 
as the CAM began to show haemorrhage and the resultant periphery blood obscured 
the visualization of the CAM vessels. The results showed that there was a slight drop 
in vessel diameter after application of 1 % v/v NMP, followed by a gradual increase 
in vessel diameter over time (Figure 39). As reported earlier, 1 % v/v NMP resulted in 
no discernible significant change in blood perfusion values. Hence, changes in blood 
perfusion of the CAM could not be solely attributed to changes in vessel diameter. 
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Figure 39. Change in vessel diameter over time with 1 % v/v NMP application on 
CAM (n = 5) 
 
F.5. Glucagon 
An increase in vessel diameter was seen with 1 mg/mL of glucagon after about 5 min 
of application to the CAM (Figure 40). The vasodilative action of glucagon was 
sustained and still evident even after an hour. However, the increase in vessel 
diameter was not accompanied by the expected increase in blood perfusion. A 
decrease in vessel diameter was accompanied by an increase in blood perfusion with 
70 % v/v ethanol. A decrease in vessel diameter coupled with almost no change in 
blood perfusion was seen with the application of 1 % v/v NMP. A probable 
supposition is that changes in vessel diameter either need to reach a certain threshold 
before any discernable change in blood perfusion can be detected, or the expected 
changes in blood perfusion following vessel diameter changes are over-riden by auto-
 RESULTS AND DISCUSSION 
  123 
regulation mechanisms of the CAM. In the case of glucagon, the increase in diameter 
may not have been adequate to result in blood perfusion change. Since the instilled 
compound produced vascular response, it was also likely to enter the circulatory 
system. Thus, besides effects on the local vasculature, there may be other systemic 
effects and changes in the cardiac contractile ability will certainly affect the overall 
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Figure 40. Change in vessel diameter over time after 1 mg/mL glucagon application 
on CAM (n = 5) 
 
F.6.  Caffeine 
A marked increase in vessel diameter was obtained after the application of caffeine on 
the CAM surface for all the caffeine doses used. This observation suggested 
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consistent evidence of vasodilation (Figure 41). The standard error bars were omitted 
for a clearer view of the plot.  
 
The plot of increase in vessel diameter ratio against caffeine concentration is shown in 
Figure 41. In an attempt to obtain a simple mathematical model to describe the effect 
of caffeine on vessel size, the caffeine dose was plotted against vessel derivatives of 
the change in vessel diameter. Derivatives employed include the percentage, log and 
square root values of the change in vessel diameter. According to the Pearson’s 
correlation test, the relationship between increase in vessel diameter and caffeine 
concentration was non-linear (p > 0.05) and best described by a U shaped pattern, 
similar to the pattern seen with the plot of blood perfusion change against caffeine 
dose (Figure 42). According to the profile, the average change in vessel diameter 
increased from 2 mg/kg to 4 mg/kg caffeine. Caffeine in dose range of 4 mg/kg to 8 
mg/kg showed similar effects on vessel diameter, resulting in a plateau on the graph. 
Further increase in caffeine concentration to 10 mg/kg increased vessel diameter 
significantly. Compared to blood perfusion, the vessel diameter was more sensitive to 
changes in caffeine dose. Change in vessel diameter has to reach a certain threshold 
before any discernable change in blood perfusion can be detected. This could possibly 
account for the greater response of vessel diameter to test substance in comparison to 
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y = 0.78x2 - 4.62x + 45.46
R2 = 0.68
y = 0.32x + 5.23
R2 = 0.60
y = 0.04x + 1.47
R2 = 0.59
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Figure 42. Relationship between caffeine dose and derivatives of change in vessel 
diameter  
 
Auto-regulation could have set in and caused compensatory mechanisms so as to 
result in changes in vessel diameter to compensate for the decrease in blood perfusion. 
This would ensure that baseline perfusion and vessel diameter parameters are 
maintained so as to protect the well being of the foetus. Alternatively, hormesis could 
have resulted (Calabrese, 2009), which lead to a balance of vasodilation and 
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vasoconstriction factors that cumulated in the pattern seen with percentage change in 
vessel diameter, which decreases with dose before subsequently increasing gradually 
pass a certain dose. In addition, the binding of caffeine to different adenosine receptor 
subtypes (Riksen et al., 2008), which result in vasodilation or the antagonism of 
vasodilation, may also play a role in the results seen. If caffeine were to bind 
preferentially to either subtype, this could affect the balance of vessel diameter and 
cause vasodilation or vasoconstriction. At higher doses, the effect of the dominant 
receptor would be predominant (Szabadi, 1977). 
 
Another possible explanation for the observed phenomenon is the concept of 
hormesis. There are two types of biphasic response. The first type illustrates a 
situation where the response variable increases above the baseline but subsequently 
decreases below the baseline as the drug dose increases. The second type 
demonstrates an opposite trend, where the response variable decreases below the 
baseline but subsequently increases above the baseline as the drug dose increases. An 
example of this time response plot is the hormesis model as shown in Figure 43. The 
hormetic dose response can perhaps provide a better explanation of the results in 
comparison with the threshold model (Calabrese and Baldwin, 2003). The inhibition 
and antagonism of adenosine by caffeine occur at the adenosine receptors. There are 
multiple subtypes of adenosine receptors that adenosine can bind and the consequence 
of selective binding results in either stimulatory or inhibitory effects on the vessels. At 
different concentrations, caffeine affects the binding of adenosine to the different 
receptors (Calabrese, 2008). A combination of these concepts can perhaps explain the 
trends observed. In the range of 2 – 4 mg/kg, caffeine appeared to be preferentially 
bound to the inhibitory adenosine receptors as indicated by the decreased blood vessel 
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diameter values. From 4 – 8 mg/kg, caffeine appeared to bind to the stimulatory and 
inhibitory receptors to similar extent as indicated by the constant change in blood 
vessel diameter. Above 8 mg/kg, the inhibitory receptors could have been saturated 
and the stimulatory effect predominated, resulting in an increase in vasodilation and 
hence, an increase in vessel diameter values. Hence, the use of caffeine as a model 
drug to investigate the influence of excipients on drug absorption should best be 
limited to the linear portion of the curve so as to provide an accurate estimation on the 
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F.7.   GTN 
The majority of the vessels used in this study were veins with diameters in the range 
of 200 to 350 µm. The change in vessel diameter over time with 0.01, 0.03 and 0.05 
mg/kg GTN is depicted in Figure 44. These concentrations were chosen as they 
produced changes in vessel diameter. The standard error bars were omitted to allow 
for clearer plots. Nitrates typically result in peak vasodilation 3 to 4 min after 
administration (Moens et al., 2005), and this trend was seen in the study. 
 
According to the Pearson’s correlation test, the relationship between change or 
percentage change in vessel diameter and GTN dose is non-linear (p > 0.05). The 
relationship is best described by the relationship depicted in Figure 45. The same 
trend was observed for change or percentage change in blood perfusion. The complex 
relationship between change in vessel diameter and GTN dose could be explained by 
the concept of hormesis.  
 
The vasodilation effect of GTN may be attributed to more than one factor. 
Vasodilation may arise through the formation of nitric oxide prior to a series of 
complex pathways that begins with the activation of the intracellular enzyme, soluble 
guanylyl cylase (sGC) and results in a cascade pathway that involves cyclic 
guanosine-3’,-5’-monophosphate (cGMP), cGMP-dependent protein kinase and 
protein phosphorylation that leads to the activation of Ca2+. GTN is converted to nitric 
oxide following intracellular bioconversion, and this is the hypothesis that is 
commonly used to explain the subsequent vasoactive effects of GTN, through the 
mediating actions of nitric oxide. However, this may not be the only way that GTN 
causes vasodilation to occur. It is possible that GTN evokes vasodilation through 
another pathway that does not result in the formation of nitric oxide as a vasoactive  
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Figure 44. Change in vessel diameter over time with 0.01, 0.03 and 0.05 mg/kg GTN 
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mediator and instead, exerts vasoactivity via the activation of sGC through another 
pathway that is activated independently of the presence of nitric oxide (Kleschyov et 
al., 2003). In addition, GTN tolerance has been reported to have developed in the 
presence of high GTN concentrations or withdrawal of GTN. The mechanisms of the 
development of tolerance to GTN is complex and various mechanisms have been 
proposed (Abou-Mohamed et al., 2000). The decrease in extent of vasodilation seen at 
higher GTN doses could have been due to the presence of tolerance to the effect of 
GTN, hence resulting in the pattern seen. 
 
F.8. Correlation between basal blood perfusion and vessel diameter of the 
CAM 
CAM vessel diameters were plotted against the CAM basal perfusion levels to 
determine if there was any relationship between vessel diameter and blood perfusion. 
The spread of values in the 2D scatter plot showed extremely poor correlations 
(Figure 46). Further analysis using the Pearson’s correlation test confirmed that the 2 
parameters were not correlated (p value > 0.05). Hence, the size of the vessels used in 
this study had insignificant effect on the results. This allowed for meaningful 
interpretation of the results from blood perfusion studies. 
 
Both GTN and caffeine are vasodilators (Kelly et al., 2005, Lapeyre et al., 2004). The 
doses of these 2 drugs used in the study generally produced vasodilation in the CAM. 
However, blood perfusion decreased instead of showing an increase that is expected 
with vasodilation. The inverse relationship is not in agreement with Poiseuille’s Law 
that states that changes in blood perfusion should be proportional to changes in vessel 
diameter. Hence, there could be a different auto-regulatory response mechanism with  
 RESULTS AND DISCUSSION 























Figure 46. Lack of relationship between blood perfusion and vessel diameter  
 
regards to vasodilation and vasoconstriction. Hyperoxia has been found to result in 
greater degree of angiogenic effect than hypoxia (Strick et al., 1991). Vasodilation 
resulted in a greater amount of blood perfusion. This could have resulted in the 
development of hyperoxia. As such, an enhanced angiogenic effect may have 
occurred. In response, a rebound reaction may have been triggered in an effort to 
restrict the hyperoxia. The rebound reaction thereby results in lower blood perfusion. 
 
Caffeine was reported to result in varying changes on blood pressure (James, 2004, 
Engels et al., 1999). According to Poiseuille’s Law, pressure is directly proportional 
to blood perfusion. Hence, any decrease in blood pressure due to the action of caffeine 
may cause blood perfusion values to decrease. Caffeine was also reported to increase 
vascular resistance (Hartley et al., 2004, James and Gregg, 2004). As mentioned 
previously, an increase in vascular resistance would result in a decrease in blood 
perfusion. In addition, caffeine was reported to alter cardiovascular performance in 
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embryos (Keller et al., 2007). Change in cardiovascular properties may alter pressure 
or output and hence affect blood perfusion of the CAM. 
 
GTN was reported in numerous studies to decrease systolic, diastolic, mean arterial, 
and central aortic blood pressure (Kawakami et al., 1995, Conti et al., 1983). 
According to Poiseuille’s Law, a decrease in pressure would result in a decrease in 
blood perfusion. GTN was also reported to cause a decrease in venous return, which 
would also decrease blood pressure and cardiac output (Kojda et al., 1996). A 
phenomenon known as the Bezold-Jarish reflex has been reported to cause 
hypotension as well as bradycardia in humans. It was postulated that the mechanism 
of action involved the stimulation of the cardioinhibitory receptors in the ventricle 
walls (Boyle, 2007) . High doses of nitric oxide arising from GTN was reported to 
reduce contractile response and blood pressure. The reduction in blood perfusion due 
to GTN could be attributed to the above mechanisms.  
 
F.8.i.  Caffeine 
The change in vessel diameter that occurred under the influence of caffeine had an 
effect on the extent of change in blood perfusion. For each caffeine dose, the mean 
change in blood perfusion and corresponding change in vessel diameter were plotted 
(Figure 47). According to the Pearson’s correlation test, the change in vessel diameter 
with caffeine concentration did not follow a linear relationship (p > 0.05). The 
relationship is best described by an inverted U-shaped curve. The initial part of the 
curve, which corresponds to dose range of 2 mg/kg to 6 mg/kg, shows a direct 
relationship between blood perfusion and vessel diameter Beyond vessel diameter of 
35 µm, which corresponds to a dose of 6 mg/kg, the change in blood perfusion 
 RESULTS AND DISCUSSION 
  135 
decreases with increase in vessel diameter change. The last 2 points on the curve 
represent the 10 mg/kg and 8 mg/kg doses respectively. These findings implied that 
concentrations greater than 6 mg/kg resulted in a smaller change in blood perfusion 
that was not dose-dependent. This may have been a result of oversaturation of the 
receptors. The complex relationship between change in vessel diameter and caffeine 





Figure 47. Relationship between blood perfusion and vessel diameter changes with 
caffeine 
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F.8.ii.  GTN  
The change in vessel diameter that occurred under the influence of GTN also had an 
effect on the extent of change in blood perfusion. For each GTN dose, the mean 
change in blood perfusion and corresponding change in vessel diameter were plotted 
(Figure 48). According to the Pearson’s correlation test, the change in vessel diameter 
with GTN dose did not follow a linear relationship (p > 0.05). Interestingly, the 
relationship followed a U-shaped curve, which is direct contrast to the inverted U-
shaped curve obtained for caffeine. The initial part of the curve shows a linear 
relationship between blood perfusion and vessel diameter. The linear relationship 
lasted till the threshold value of 15 µm. After the threshold value, the change in blood 
perfusion plateaued and then increased with an increase in vessel diameter. This 
relationship did not occur concurrently with the doses of GTN applied topically to the 
CAM. Low concentrations of GTN were shown to result in greater changes in vessel 
diameter as opposed to the higher concentrations of GTN used. The low GTN 
concentrations such as 0.008 mg/kg and 0.02 mg/kg also resulted in the greatest 
change in blood perfusion compared to the other GTN concentrations. Hence, this 
shows that blood perfusion change in the CAM is more sensitive to low 
concentrations of GTN and would react in accordance to this sensitivity. With the 
exception of the lowest GTN concentration of 0.008 mg/kg, the low range of GTN 
concentrations cause an increased change in vessel diameter in contrast to the higher 
range of GTN concentrations. However, the change does not occur in a dose 
dependent manner. There is a possibility of the receptors being saturated at higher 
concentrations of GTN. The use of GTN as a model drug would be appropriate if the 
low ranges of concentrations are used. The complex relationship between change in 
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vessel diameter and GTN concentration could be explained by the concept of 
hormesis. 
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Figure 48. Relationship between blood perfusion and vessel diameter changes with 
GTN. The points from left to right refer to the concentration of 0.008 mg/kg, 0.1 
mg/kg, 0.15 mg/kg, 0.2 mg/kg, 0.5 mg/kg, 0.03 mg/kg, 0.05 mg/kg, 0.01 mg/kg and 
0.02 mg/kg respectively 
 
 
F.9.  Diameter ratio 
F.9.i.  Caffeine 
The diameter ratios obtained for caffeine showed a dose dependent trend (Figure 49). 
Diameter ratio increased when the concentration of caffeine was increased. This 
meant that an increase in caffeine dose resulted in a greater increase in vessel 
diameter of the CAM. Perfusion ratio versus dose was also plotted on the same graph. 
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A downward sloping line was obtained, however, it was almost horizontal, signifying 
that there was little change in perfusion ratio with caffeine dose. 
 
y = 0.01x2 - 0.04x + 1.18
R2 = 0.89
























The diameter ratios obtained for GTN showed a dose dependent trend (Figure 50). 
The values of the diameter ratio increased gradually when the dose of GTN was 
increased. The plot of perfusion ratio with GTN dose showed an almost horizontal 
line, indicating that GTN has little effect on the perfusion ratio. The vasodilation 
exerted by caffeine was of greater magnitude than the vasodilation caused by GTN. 
Hence, caffeine may be a better choice to act as a model drug in studies focused on 
vessel diameter change.  
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y = 1.75x2 - 0.91x + 1.13
R2 = 0.22


















Figure 50. Effect of GTN concentration on perfusion ratio and diameter ratio 
 
G. Permeation studies 
G.1.  Permeation studies with the Franz diffusion cell 
Nicotine was used as the model drug as it possesses good solubility in both polar and 
non-polar solvents. Its low molecular weight also aligns it to be a good penetrator 
(Zorin et al., 1999). In addition, GTN was chosen for its clinical relevance to buccal 
mucosa. Photographs of the CAM, snake skin and pig skin are shown in Figure 51. 
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Figure 51. Photographs of (a) CAM in egg, (b) CAM specimen, (c) snake skin 
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G.2.  Influence of partition coefficient and molecular weight of drug on 
permeation through the CAM 
The model drugs used possess different partition coefficients (nicotine, 1.17 and 
GTN, 1.62) and molecular weights (nicotine, 162.2 and GTN, 227.1). Using the skin 
as a guide, a drug with a log10 partition coefficient value of less than or equals to 2 is 
considered as a potential candidate to penetrate the skin (Beetge et al., 2000). The 
partition coefficient refers to the ratio of the solubility of the compound in octanol 
over the solubility of the compound in water. A drug requires a balance in order to be 
able to permeate through the skin and subsequently into the systemic circulation. In 
the case of the CAM, the drug would need to partition through the mesoderm of the 
CAM and penetrate the extracellular matrix which is composed of many different 
types of material such as laminin, collagen type IV, fibronectin and various 
glycosaminoglycans (Ribatti, 2008). GTN has a partition coefficient that falls within 
the proposed optimum range of values that are less than or equal to 2. This probably 
explains its rapid action in the CAM as quick responses were observed. However, 
propranolol which has a partition coefficient outside the stated range, also affected 
blood flow and caused hemorrhage in the CAM. This shows that propranolol (with a 
partition coefficient value of 3.48) was accessible to the blood vessels in the CAM, 
probably to a lower extent in comparison with GTN. Furthermore, theophylline has 
partition coefficient (-0.02) and molecular weight (198.2) comparable to those of 
caffeine (partition coefficient value and molecular weight of -0.07 and 194.2 
respectively). A molecular weight of less than 600 Daltons is more permeable through 
the skin (Aulton, 2001). Unlike caffeine, theophylline was unable to elicit a response 
in the CAM blood perfusion measurements. As discussed earlier, metabolism of 
theophylline to caffeine is a prerequisite before it can exert its effects on blood 
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perfusion. The enzymes required for this metabolism to take place are found in human 
skin but not in the CAM. Therefore, the CAM may not be an ideal model for the 
human skin but for biological membranes. Such possible membranes probably include 
the non-keratinised retina tissue of the eye or the buccal mucosa, based on the 
structural characteristics of these membranes in comparison with the CAM (Table 2). 
The suitability of the CAM to mimic human membrane was further investigated.  
 
G.3.  Nicotine 
G.3.i.  Synthetic membrane 
In a separate control study, the synthetic membranes were placed onto the receptor 
compartment without any biological membrane to determine the effect of the 
synthetic membrane on the drug release profile. The synthetic membrane served to 
provide structural support to the test membrane. Hydrophobic membranes were 
avoided as they were found to be poorly wetted by the receptor fluid. Poor wetting of 
the membrane was found to affect the release of nitroglycerin (Shargel, 2005). The 
compatibility of the membrane with the buffer solutions rendered it to be suitable for 
use, as it did not dissolve or degrade on contract with the buffer solution. The CAM 
was supported on the synthetic membrane and the release rate of nicotine through the 
CAM determined. In a preliminary study, the amount of nicotine that permeated 
through the synthetic membrane reached a plateau within an hour. Furthermore, the 
amount of drug that permeated through the synthetic membrane was higher than the 
amount of drug that eventually permeated through the combination of test membranes 
and synthetic membrane, except for pig retina. This showed that the presence of the 
synthetic membrane did not pose a barrier to drug permeation and hinder the rate at 
which nicotine permeated through the other biological membranes (Figure 52). 
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Figure 52. Permeation profiles of nicotine through different membranes (n = 3) 
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G.3.ii.  Fresh CAM 
G.3.ii.a Influence of CAM thickness 
The thickness of the CAM obtained from fertilized eggs of different age was 
measured. The thickness of the CAM was found to increase linearly with embryo age 
in an exponential manner (r2 0.94) (Figure 53). The standard error values are so small 
that they cannot be seen on the graph, indicating the robustness and reproducibility of 
CAM thickness with embryo age. The values are in agreement with reported CAM 
thickness values of between 100 – 150 µm (Kurz et al., 1994). The thickness of the 
CAM can be attributed to the increase in vascularity as well as the changing cell 
compositions in the CAM layers that result in the formation of intercellular spaces, 
vacuolation of cytoplasm and accumulation of excretory waste. No definite trend was 
observed between CAM thickness and the permeation profile of nicotine through the 
CAM at different EAs (Figure 54). Hence, CAM thickness was not a determining 
factor of permeation through the CAM. 
 
G.3.ii.b. Permeation properties through fresh CAM 
It would be optimal to employ fresh CAM in experiments as it has been found that 
freshly harvested animal skin retained most of the characteristics of living skin 
(Yazdanian, 1994). The typical permeation profile of nicotine through the CAM is 
depicted in Figure 52. Irrespective of embryo age, the total amount of nicotine that 
permeated through the CAM reached a plateau after about 5 h. Some examples are 
shown in Figure 55. However, the permeation coefficient of the CAM was found to 
vary with embryo age (p value < 0.05) (Table 13). This suggested that the 
composition of the CAM that varied with age may play a role in affecting permeation  
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Table 13. Kp values of test membranes with nicotine 




 9 0.129 4.98 
 10 0.180 15.9 
 11 0.181 17.7 
 12 0.152 23.5 
Fresh CAM 13 0.127 10.9 
 14 0.170 29.2 
 15 0.130 28.7 
 16 0.156 14.8 
 17 0.130 24.8 
 18 0.132 21.2 
 9 0.188 5.06 
 10 0.202 11.5 
 11 0.357 4.53 
 12 0.292 11.3 
 13 0.217 7.58 
Frozen CAM 14 0.199 2.96 
 15 0.238 24.3 
 16 0.291 0.758 
 17 0.334 2.12 
 18 0.307 1.86 
Snake skin  0.011 36.8 
Pig Skin  0.003 13.4 
Pig retina  0.473 57.9 
Pig buccal 
mucosa 
 0.133 47.1 
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Figure 54. Relationship between CAM thickness and permeability coefficient 
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Figure 55. Permeation profiles of nicotine through CAM of different EA (n = 3) 
 
through the CAM. The properties of fresh CAM, in comparison with the other 
biological membranes, will be discussed in subsequent sections. 
 
The CAM consists of three layers as mentioned in the introduction. The ectoderm, 
mesoderm and endoderm, which grow at different rates and exhibit different 
morphological characteristics. The ectoderm is made up of a majority of cuboidal 
cells while the mesoderm is composed of a matrix which consists of blood vessels and 
cells with fibrillar material. The endoderm consists of squamous and cuboidal cells. 
As the egg matures, these cells change to columnar type and large intercellular spaces 
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appear after EA 16. Light and electron microscopy have shown the ectoderm layer to 
be the densest with the most closely packed cells. Hence, it is likely that the greatest 
barrier to permeation through the CAM would be the ectoderm layer. After EA 10, the 
ectoderm proliferates non-uniformly until it is at least 8 cells thick. It reaches a 
maximum thickness at EA 14 and disappears after EA 15. As such, gradual decrease 
in Kp value after EA 10 and minimum Kp value at EA 14 would be expected. 
 
According to the results, the change in Kp values with embryo age could be roughly 
accounted by the morphological change of the ectoderm (Table 13). The Kp value of 
fresh CAM was seen to decrease after EA 10 and reaches a minimum at EA 13 before 
increasing at EA 14, decreasing at EA 15 before increasing again at EA 16 and finally 
reaching a plateau at EA17 and EA 18 (Figure 56). However, the Kp values from EA 
15 to EA 18 can almost be regarded as similar because of the overlapping standard 
error. The slight deviation from the expected trend showed that the mesoderm and 
endoderm also affected the permeation of nicotine, but to a smaller extent. There was 
an increase in the endothelium of the larger vessels in the mesoderm after EA 15 
(Romanoff, 1960, Shumko et al., 1988). This increase in endothelium, which may 
pose a barrier to permeation could account for the lower Kp values after EA 14 instead 
of the expected increase. 
 
The Kp of nicotine for each EA of fresh and frozen CAM as well as that for pig skin, 
snake skin, pig buccal mucosa and pig retina tissue was calculated from the flux 
values obtained (Table 13).   
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Figure 56. Plots of EA versus Kp for nicotine through frozen and fresh CAMs (n = 3) 
 
G.3.iii.  Frozen CAM 
Permeation study was also conducted using frozen CAM of EA 9 to EA 18 so as to 
investigate the effect of freezing on the permeability profile of nicotine through the 
CAM. The permeability profile of nicotine through the frozen CAM is shown in 
Figure 52. In comparison with the permeability profile of freshly harvested CAM, the 
amount that eventually permeated through the frozen CAM is higher.  
 
The plot of Kp versus EA is shown in Figure 56 for fresh CAM and frozen CAM. 
Irrespective of the embryo age, the shapes of both graphs are roughly similar.  
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The Kp values of frozen CAM are higher than the values obtained for fresh CAM. 
Statistically significant differences in flux values between fresh and frozen porcine 
buccal mucosa were also reported (Van Eyk and Van der Biijl, 2006). Freezing has 
been found to cause an increase in permeability through the skin. This is a result of 
the formation of ice crystals from water in the skin as well as disorganization of lipids 
that damages the keratinocytes and the lipid matrix of the rate – limiting stratum 
corneum (Ahlstrom et al., 2007, Babu et al., 2003, Kemppainen et al., 1986, 
Swarbrick et al., 1982). Mechanical damage and osmotic effects have also been 
proposed as possible mechanisms of destruction (Schafer and Kaufmann, 1999). 
These changes to the diffusion pathway would result in an increase in the 
permeability of the skin, affecting the pathways through which the drugs pass 
through. Similar effects are likely to occur to other tissues. 
 
Hence, freezing should be avoided so as to prevent formation of ice crystals and 
changes to lipid structure of the CAM. However, fresh CAM, especially those of 
specific EA, may not be readily available. In the event that frozen CAM is used, the 
results should be interpreted appropriately with respect to the trends seen with frozen 
CAM. 
 
G.3.iv.  Pig skin 
Pig skin is regarded as one of the most well-suited animal models for human skin 
(Barbero and Frasch, 2009, Lin et al., 1992). The Kp value obtained for pig skin was 
similar to that obtained from previous studies which compared pig skin to human skin 
(Maibach and Bronaugh, 2002). The permeation profile of nicotine through pig skin 
shows that the total amount of permeated nicotine was lower than that of fresh and 
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frozen CAM. In addition, it took a longer time for nicotine to reach a plateau in pig 
skin as compared to the CAM (Figure 52). These Kp values of the pig skin were 
significantly lower than those of fresh and frozen CAMs but similar to the Kp value of 
0.0039 cm/h for human skin (Berner et al., 1992). This indicates that the permeation 
profile through pig skin resembles that of human skin, but not the CAM. Hence, the 
CAM would not be suitable as a skin model. The metabolizing capabilities of the skin 
is largely attributed to the viable epidermis (Zwadlo-Klarwasser et al., 2001). In this 
case, the pig skin was frozen prior to use and the tissue was not viable, hence 
metabolism of nicotine could not have occurred. The stratum corneum is 13 - 17 µm 
thick, consisting of 10 – 20 layers of keratin rich corneocytes and lipid layers. The 
corneocytes are embedded in an extracellular lipid matrix that is arranged in an 
orderly manner. This complex arrangement of corneocytes and lipids is referred to as 
the brick and mortar model and accounts for the main barrier to drug permeation 
through the skin. (Dupuis et al., 1984). In addition, a full thickness specimen of pig 
skin was used. The presence of the stratum corneum in the pig skin could have posed 
a permeation barrier and accounted for the significantly lower amount of nicotine that 
permeated through as compared to the CAM which does not possess a stratum 
corneum.  
 
G.3.v.  Snake skin 
A slower rate of permeation of nicotine was observed, which is in agreement with the 
findings from a previous study (Pongjanyakul et al., 2002). This demonstrates the 
reproducibility of permeation experiments through snake skin. The Kp value of the 
snake skin was significantly lower than those of the fresh and frozen CAMs but 
higher than that of pig skin. Snake skin is easily available without causing harm to the 
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snake as a relatively large amount of skin is shed from the same snake periodically. 
Shed snake skin consists of 3 layers of non-living pure stratum corneum that do not 
contain hair follicles. It has a beta keratin rich outermost layer, alpha keratin and lipid 
rich intermediate mesos layer and finally an alpha keratin rich innermost layer. It is 
the intermediate mesos layer, which has three to five layers of cornified cells enclosed 
by intercellular lipids that accounts for the similarity to human stratum corneum. The 
stratum corneum components such as glycosphinolipids and ceramides, as well as the 
vascular structures and collageneous connective tissues are similar in both snake and 
human skin (Godin and Touitou, 2007). Snake skin has been used as a model for 
human skin due to its similarity to the stratum corneum of the human skin (Takahashi 
and Rytting, 2001). However, the absence of hair follicles accounts for snake skin 
being less permeable than human skin because hair follicles contribute to an increase 
in permeability (Barbero and Frasch, 2009). The Kp value of snake skin is higher than 
that of pig skin. The stratum corneum layer in pig skin (26.4 ± 0.4 µm) is thicker 
compared to the stratum corneum in the snake skin  (10 - 20 µm) (Maibach and 
Bronaugh, 2002, Itoh et al., 1990). Hence, the difference in permeability of the snake 
skin and pig skin may be due to the thicker stratum corneum in pig skin. Therefore, 
snake skin may not be a suitable model for human skin.  
 
G.3.vi.  Retina tissue 
The organs and membranes of pigs have been considered structurally similar to 
human parts. The permeation profile of nicotine through retina tissue showed that the 
total amount of permeated nicotine was significantly higher than that of fresh and 
frozen CAM. The average Kp value of the retina was significantly higher than those of 
fresh and frozen CAM. Some of the retina samples still retained the pigments at the 
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time of experimentation. The retinal pigment epithelium and endothelial membrane of 
the retinal vessels possess tight junctions that are non-leaky (Cunhavaz, 1980). The 
CAM is of comparable thickness to human retina, which is approximately 100 – 300 
µm. Furthermore, the tissue responses of in vitro CAM have been found to be similar 
to in vivo rabbit retina (Leng et al., 2004). The preparation process was tedious and 
required careful handling as the retina is a very delicate piece of tissue. There could 
have been holes in the retina tissue that resulted from the preparation procedure that 
were not visible to the naked eye. The presence of holes could have lead to a higher 
Kp value as compared to the other biological membranes as well as higher standard 
error values. However, it is more likely that the absence of the retinal pigmented 
epithelium was responsible for the higher Kp value. The retinal pigmented epithelium 
exhibits tight junctions which form a barrier to molecules into the retina (Duvvuri et 
al., 2003). The process of removing the retina and soaking it in isotonic phosphate 
buffer resulted in the loss of the retinal pigmented epithelium. Hence, more nicotine 
was able to permeate through the piece of retina, resulting in a higher Kp value. 
 
G.3.vii. Buccal mucosa 
The permeation profile of nicotine through pig buccal mucosa showed that the total 
amount of nicotine that permeated through the buccal mucosa was higher than those 
through fresh CAM. However, the Kp values of the buccal mucosa and fresh CAM 
were comparable. The pig buccal mucosa in this study has been found to be 44 times 
more permeable than the pig skin, which is widely used as a human skin model. The 
buccal mucosa is suitable for the delivery of macromolecules and hydrophilic 
compounds (Tanojo et al., 1999). The pig buccal mucosa was chosen as an alternative 
to human buccal mucosa because of the similarities in structure. Rabbit buccal 
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mucosa is the closest to human buccal mucosa in terms of structure. However, 
keratinization occurs in the rabbit tissue in patchy areas. This leads to limited areas 
available for permeation studies. Hamster buccal epithelium is also another viable 
option, however the available area for experimentation is too small (Tavakoli-Saberi 
and Audus, 1989). The next best option is pig buccal mucosa. Pig buccal mucosa is 
the most commonly used model for human buccal mucosa to date due to its 
availability and low cost (Obradovic and Hidalgo, 2008). The presence of membrane 
coating granules located in the upper third portion of the epithelium has been 
attributed to causing the permeability barrier in oral mucosa. The pH of the phosphate 
buffer in the Franz diffusion cell is also similar to the pH of saliva which ranges from 
5.5 to 8 depending on the flow rate of saliva (Shojaei, 1998). Human buccal tissue 
allows only a few milligrams of drug to pass through (Zhang et al., 2002) and in this 
respect, the permeation profile through pig buccal mucosa is similar to that of human 
buccal tissue. Studies with nicotine have shown that nicotine from chewing gum 
reaches a peak plasma concentration at 30 minutes after the gum is first chewed. In 
this study, nicotine reached peak amount permeated through at close to 30 minutes. 
Drug is presumed to pass through human buccal mucosa through the paracellular and 
transcellular routes particularly for hydrophilic and hydrophobic compounds 
respectively. Since nicotine is hydrophilic, the passage of nicotine through the CAM 
could potentially be through the paracellular route and by passive diffusion (Adrian et 
al., 2006). Although the average thickness of the buccal mucosa is 500 – 600 µm, and 
much thicker than the CAM (Nicolazzo and Finnin, 2008), the similarity between 
CAM and buccal mucosa permeation profile paves the possibility of the CAM being 
used as a substitute for human buccal mucosa instead of pig buccal mucosa. Cell 
cultures of human buccal mucosa are available but limited information and studies 
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have been done on them. The prospect of the CAM being a human buccal model has 
many advantages over the pig buccal mucosa. There is the possibility of tissue 
damage to the buccal mucosa that may occur when the pig masticates and accidentally 
bites the buccal mucosa. The CAM is kept in a protected environment in the egg away 
from physical assaults from the environment. Tissue acquisition from pigs is also a 
more laborious and time intensive procedure as opposed to harvesting the CAM. 
More costs are incurred with the maintenance of pigs to suitable age for 
experimentation and also to sacrifice them in a humane manner. Most importantly, 
there is the lack of ethical issues surrounding the use of CAM that are less than EA 10 
in age. 
 
G.4.  GTN 
The similarity between the CAM and buccal mucosa provided the impetus to 
investigate the permeation profile of a drug commonly used on the buccal mucosa. 
The most commonly used drug for buccal delivery is GTN for rapid treatment of 
acute attacks of angina pectoris. GTN is employed as a sublingual tablet administered 
to the surface of the buccal mucosa. The blood perfusion studies have indicated that 
the formulation additives present in GTN tablets may be an influencing factor. Hence, 
the injection form was used in a bid to overcome the formulation effects.   
 
The HPLC standards of GTN were problematical. The limit of detection of GTN with 
the HPLC was higher than the amount of GTN present in the samples withdrawn from 
the Franz cell. The limiting factor was the maximum concentration of the stock GTN 
solution that was added to the CAM surface when it was introduced into the donor 
compartment of the Franz cell. Such analytical difficulties with regards to the 
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detection of GTN have been documented (Cossum and Roberts, 1985). GTN solutions 
could not be reconstituted as GTN was not available in powder form as it is 
considered to be an explosive and its import and sale are highly controlled.  
 
The results from this study shows that the CAM in vivo model is still more sensitive 
that the in vitro model. The topical application of GTN on the CAM demonstrated 
changes in blood perfusion and vessel diameter studies. The CAM is able to detect the 
minute concentration of GTN that was not detectable with HPLC. The CAM tissue 
was used fresh after being sacrificed. Hence, the CAM tissue could have still been 
viable in the early part of the study. GTN has been reported to be metabolized by 
epidermal enzymes into 1,2 – and 1,3 – glyceryldinitrate metabolites (Higo et al., 
1992). This could indicate the presence of enzymes in the CAM that could have 
depleted the amount of GTN to low levels that was not accurately detected with 
HPLC. In the in vivo studies, it was possible that either the blood perfusion and vessel 
diameter responses occurred before the metabolism of GTN or that metabolism did 
occur but therapeutically sufficient levels of GTN were still present to induce vessel 
diameter and blood perfusion changes in the CAM. 
 
 In summary, the application of the CAM has been shown to be most suitable for use 
as a model for the pig buccal biological membrane in the assessment of drug 
permeation. As pig buccal mucosa is commonly used as a model for human buccal 
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CONCLUSIONS 
 
The aim of this project was to develop an alternative in vivo / in vitro model for 
assessing drug absorption in pharmaceutical product development.  
 
The CAM was employed successfully as a screening tool for irritation effects. Thus, it 
was able to screen for suitable drugs and solvents to be used in subsequent blood 
perfusion and diameter measurements.  
 
Two imaging based-in vivo CAM models that involved blood perfusion and vessel 
dimensions of the CAM were developed. The CAM was successfully prepared by a 
partial deshelling method. The age of the CAM was an important consideration as it 
was harder to perform the deshelling process with older embryos. Younger embryos 
were prone to succumbing after the deshelling process. Diameters of the CAM blood 
vessels could be measured accurately using high resolution video imaging and image 
analysis system with customized software. Blood perfusion of the CAM could be 
measured by the non-invasive LDPI method rapidly. The readings were significantly 
affected by amplitude and threshold. The relationships of blood perfusion and vessel 
size with drug concentration were generally complex due to auto-regulation 
mechanisms. Change in vessel size was a better indication of drug absorption than 
blood perfusion.  
 
The CAM was also evaluated as an in vitro model for drug permeation using the 
Franz diffusion cell. The CAM was easily removed from the egg at EA 13. The frozen 
CAM was more permeable than the fresh CAM. The CAM was also most similar to 
the buccal mucosa as opposed to skin or retina tissue in terms of permeation profile 
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and permeability coefficient values. Hence, the CAM shows promise and potential as 
as an in vitro buccal model. It is also potentially useful as a “live” in vivo model for 
assessing formulations and drug absorption for buccal delivery. 
 
Further studies using formulation variables are recommended to verify this model 
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